aldosterone has been researched along with Liver Cirrhosis in 395 studies
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
"Adding rifaximin and midodrine to DT enhanced diuresis in refractory ascites with improved systemic, renal hemodynamics and short-term survival." | 9.22 | Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. ( Hanafy, AS; Hassaneen, AM, 2016) |
"Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 8.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
"Synthetic mineralocorticoid, fludrocortisone, was administered for 7 days to 8 patients with non-ascitic liver cirrhosis (LC) and 6 controls (CO) on a high sodium diet." | 7.69 | [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis]. ( Horký, K; Jedlicka, J; Marecek, Z; Spicák, J; Tesar, V; Widimský, J; Zabka, J, 1994) |
"We compared acute hemodynamic, hormonal, and natriuretic responses to a single oral dose of captopril (50 mg) versus enalapril maleate (10 mg) administered to eight patients with biopsy-proved liver cirrhosis." | 7.68 | Intrapatient comparison of acute hemodynamic, hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis. ( Ishizaki, T; Murakami, S; Ohnishi, A; Tanaka, T, 1990) |
"The plasma levels of atrial natriuretic factor in liver cirrhosis can be affected by various factors, such as ascites, renal function, use of diuretics drugs and dietary sodium intake." | 7.68 | Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. ( Badalamenti, S; Dioguardi, N; Incerti, P; Lorenzano, E; Moser, P; Salerno, F, 1990) |
"Renal tubular sodium handling was evaluated in 27 non-azotemic cirrhotic patients with ascites and positive sodium balance and in 17 controls after at least 5 days of a constant sodium intake using the lithium clearance as an index of fluid delivery to the distal tubule." | 7.68 | Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. ( Angeli, P; Caregaro, L; de Toni, R; Gatta, A; Menon, F; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D, 1990) |
"We investigated the renal and humoral effects of short-term administration of ibopamine, an orally active dopamine agonist, in patients with liver cirrhosis." | 7.68 | Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis. ( Badalamenti, S; Ghirardi, P; Graziani, G; Incerti, P; Lorenzano, E; Morganti, A; Salerno, F, 1990) |
" The aim of this study was to evaluate the effect of diltiazem on renal function, renin-angiotensin-aldosterone axis (RAA) and atrial natriuretic factor (ANF) in patients with liver cirrhosis." | 7.68 | Effect of diltiazem on renal function in patients with liver cirrhosis. ( Aran, S; Berkman, K; Kalayci, C; Ozdogan, O; Taga, Y; Tankurt, E; Tözün, N, 1991) |
"We have previously shown that unresponsiveness to atrial natriuretic factor is a marker of the severity of ascites." | 7.68 | Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. ( Blendis, LM; Morali, GA; Skorecki, KL; Tobe, SW, 1992) |
"Cirrhotic patients with ascites refractory to diuretics also have blunted response to marked elevations of plasma atrial natriuretic factor levels alone or to moderate intravascular volume expansion by head-out water immersion." | 7.68 | Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. ( Blendis, LM; Legault, L; Logan, AG; Skorecki, K; Tobe, S; Wong, F, 1993) |
"Human atrial natriuretic factor (ANF) levels were measured before and after peritoneovenous shunt implantation in 10 cirrhotic patients with ascites, in whom sodium retention is a major clinical problem." | 7.67 | Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. ( Hartter, E; Klepetko, W; Miholics, J; Moeschl, P; Müller, C; Schwarz, C; Woloszczuk, W, 1988) |
"kg body wt for 45 min) of synthetic human atrial natriuretic factor (hANF) on renal hemodynamics and the renin-angiotensin-aldosterone system in 15 cirrhotic patients with ascites." | 7.67 | Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. ( Baldi, E; Cominelli, F; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E; Pinzani, M; Renzi, D, 1989) |
"Plasma levels of atrial natriuretic factor (ANP) were examined in 12 patients with liver cirrhosis (6 with ascites) and 6 controls before and after the administration of the infusion of 2000 ml of saline solution per 70 kg of body weight during 2 hours." | 7.67 | Atrial natriuretic factor in liver cirrhosis--the influence of volume expansion. ( Brodanová, M; Gregorová, I; Hirsa, M; Horký, K; Kordac, V; Kozáková, M; Petrýl, J; Tesar, V, 1989) |
"Plasma immunoreactive atrial natriuretic factor (irANF) levels and the effects of alpha-human ANF (alpha-hANF) infusion were investigated in 7 patients with liver cirrhosis and ascites." | 7.67 | Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. ( Beretta-Piccoli, C; Ferrier, C; Gnädinger, MP; Saxenhofer, H; Shaw, S; Suchecka-Rachon, K; Weidmann, P, 1989) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 7.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
"Seven patients with persistent hyponatremia but normal or elevated serum arginine vasopressin levels and refractory ascites undergoing peritoneovenous shunting were studied in a Metabolic Unit on a 20 mEq sodium 1200 ml fluid-restricted diet to elucidate the mechanism of this response." | 7.66 | Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. ( Blendis, LM; Langer, B; Reznick, RK; Seif, S; Taylor, BR, 1983) |
"[1-Sarcosine, 8-Isoleucine] angiotensin II was given to 8 patients with cirrhosis and ascites and 7 cirrhotic patients without ascites on a regular diet." | 7.66 | Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites. ( Hata, T; Kumahara, Y; Mandai, T; Mikami, H; Nakamaru, M; Ogihara, T, 1979) |
"Decompensated liver cirrhosis is characterized by activation of the renin-angiotensin-aldosterone system (RAAS)." | 5.35 | Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. ( Boomsma, F; Danser, AH; de Man, R; Kuiper, JJ; van Buren, H; van den Meiracker, AH, 2008) |
"Substance P is a potent vasodilatory peptide produced by the enteric nervous system and partly cleared by the liver." | 5.29 | Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. ( Andrade, A; Fernández-Rodriguez, CM; Núñez, M; Penas, J; Prieto, J; Quiroga, J; Sangro, B; Zozoya, JM, 1995) |
"All of the patients had early-stage liver cirrhosis; according to Child's classification, nine patients had group A; three, group B cirrhosis." | 5.29 | The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children. ( Januszewicz, P; Socha, J; Warnawin, K; Winnicki, C, 1994) |
"Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 5.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
" The dosage of spironolactone needed to induce a negative sodium balance correlated significantly with plasma aldosterone concentration: r = 0." | 5.27 | Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. ( Bernardi, M; Gasbarrini, G; Rusticali, AG; Servadei, D; Trevisani, F, 1985) |
"Patients with marked edema due to congestive heart failure had plasma levels of atrial natriuretic factor five times higher than normal (P less than 0." | 5.27 | Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. ( Grekin, RJ; Ostafin, EA; Shenker, Y; Sider, RS, 1985) |
"Thirty-seven patients with liver cirrhosis (16 without ascites: group 1; 21 with untreated ascites at the first onset: group 2) were studied during controlled sodium intake (40 mmol/day)." | 5.27 | Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. ( Bernardi, M; De Palma, R; Gasbarrini, G; Santini, C; Trevisani, F, 1983) |
" A simple clinical method using the urinary Na/K ratio as a guide to spironolactone dosage is outlined." | 5.25 | Spironolactone diuresis in patients with cirrhosis and ascites. ( Eggert, RC, 1970) |
"Adding rifaximin and midodrine to DT enhanced diuresis in refractory ascites with improved systemic, renal hemodynamics and short-term survival." | 5.22 | Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival. ( Hanafy, AS; Hassaneen, AM, 2016) |
"Fifty patients with cirrhosis and tense refractory ascites were randomly assigned to be treated with either midodrine (n=25) (12." | 5.19 | Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study. ( ElBaz, AA; Hamdy, H; Hassan, A; Hassanin, O, 2014) |
"This pilot study suggests that midodrine is not as effective as albumin in preventing circulatory dysfunction after large-volume paracentesis in patients with cirrhosis and ascites." | 5.13 | Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study. ( Appenrodt, B; Grünhage, F; Heller, J; Lammert, F; Rabe, C; Sauerbruch, T; Schepke, M; Trebicka, J; Wolf, A, 2008) |
"Forty patients with cirrhosis and tense ascites underwent therapeutic paracentesis with albumin or terlipressin in a randomized pilot study at a tertiary center." | 5.12 | Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study. ( Kumar, R; Nain, CK; Sharma, AK; Singh, B; Singh, V, 2006) |
"Twenty nonazotemic cirrhotic patients with ascites were treated with furosemide and spironolactone." | 5.12 | The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. ( Economou, M; Kalambokis, G; Kosta, P; Papadimitriou, K; Tsianos, EV, 2006) |
"Five patients (three in the placebo and two in the spironolactone group) abandoned the treatment prior to ascites recurrence or the end of the study due to complications or lack of compliance." | 5.08 | Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. ( Adler, M; Arroyo, V; Elewaut, A; Fernández-Esparrach, G; Geuvel, A; Ginès, P; Guevara, M; Jiménez, W; Lebrec, D; Pardo, A; Planas, R; Sort, P, 1997) |
"Ninety cirrhotic patients with ascites were studied after administration of HSS infusion (n=25) or etilefrine tablets (n=25), or both (n=25) plus standard diuretics therapy (SDT), or SDT alone (n=15)." | 4.12 | Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites. ( Badra, G; El-Haggar, S; El-Said, H; Ibrahim, O; Radwan, H, 2022) |
"Patients with cirrhosis and refractory ascites without renal dysfunction had systemic hemodynamics, renal function, and neurohormones (plasma active renin, aldosterone, norepinephrine and angiotensin II) measured pre- and 6 days post-paracentesis." | 3.83 | Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study. ( James, PD; Tan, HK; Wong, F, 2016) |
"Ten patients with preascitic (Child-Pugh A) liver cirrhosis and 10 healthy subjects underwent the following measurements during recumbency and then after four hours of standing: (a) active renin and aldosterone plasma levels; and (b) renal clearance of creatinine, sodium, potassium, and lithium (an index of fluid delivery to the loop of Henle)." | 3.71 | Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback. ( Biava, AM; Bonardi, L; Ferrari, A; Rizzetto, M; Rosina, F; Sansoè, G; Silvano, S; Smedile, A; Touscoz, A, 2002) |
"Synthetic mineralocorticoid, fludrocortisone, was administered for 7 days to 8 patients with non-ascitic liver cirrhosis (LC) and 6 controls (CO) on a high sodium diet." | 3.69 | [Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis]. ( Horký, K; Jedlicka, J; Marecek, Z; Spicák, J; Tesar, V; Widimský, J; Zabka, J, 1994) |
" the main representatives of sodium retaining systems, and of the atrial natriuretic factor (ANF) the decisive natriuretic substance in acute expansion of the extracellular volume (ECV) by infusion of two litres of saline in six controls, seven patients with essential hypertension and liver cirrhosis without ascites (6 patients) and with ascites (6 patients)." | 3.68 | [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading]. ( Dvoráková, J; Gregorová, I; Horký, K; Srámková, J; Tesar, V, 1990) |
"We compared acute hemodynamic, hormonal, and natriuretic responses to a single oral dose of captopril (50 mg) versus enalapril maleate (10 mg) administered to eight patients with biopsy-proved liver cirrhosis." | 3.68 | Intrapatient comparison of acute hemodynamic, hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis. ( Ishizaki, T; Murakami, S; Ohnishi, A; Tanaka, T, 1990) |
"We have previously shown that unresponsiveness to atrial natriuretic factor is a marker of the severity of ascites." | 3.68 | Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol. ( Blendis, LM; Morali, GA; Skorecki, KL; Tobe, SW, 1992) |
"The plasma levels of atrial natriuretic factor in liver cirrhosis can be affected by various factors, such as ascites, renal function, use of diuretics drugs and dietary sodium intake." | 3.68 | Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis. ( Badalamenti, S; Dioguardi, N; Incerti, P; Lorenzano, E; Moser, P; Salerno, F, 1990) |
"We investigated the renal and humoral effects of short-term administration of ibopamine, an orally active dopamine agonist, in patients with liver cirrhosis." | 3.68 | Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis. ( Badalamenti, S; Ghirardi, P; Graziani, G; Incerti, P; Lorenzano, E; Morganti, A; Salerno, F, 1990) |
"Cirrhotic patients with ascites refractory to diuretics also have blunted response to marked elevations of plasma atrial natriuretic factor levels alone or to moderate intravascular volume expansion by head-out water immersion." | 3.68 | Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. ( Blendis, LM; Legault, L; Logan, AG; Skorecki, K; Tobe, S; Wong, F, 1993) |
"A 49-year-old man with liver cirrhosis and hypertension was found to have hyperkalemia out of a degree of renal insufficiency and metabolic acidosis with low to normal anion gap, aggravated by volume contraction with diarrhea and medications (captopril, spironolactone and atenolol) interfering with potassium homeostasis." | 3.68 | Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension. ( Ahn, YH; Chang, DK; Choi, JW; Kee, CS; Kim, HJ, 1993) |
" The aim of this study was to evaluate the effect of diltiazem on renal function, renin-angiotensin-aldosterone axis (RAA) and atrial natriuretic factor (ANF) in patients with liver cirrhosis." | 3.68 | Effect of diltiazem on renal function in patients with liver cirrhosis. ( Aran, S; Berkman, K; Kalayci, C; Ozdogan, O; Taga, Y; Tankurt, E; Tözün, N, 1991) |
"Renal tubular sodium handling was evaluated in 27 non-azotemic cirrhotic patients with ascites and positive sodium balance and in 17 controls after at least 5 days of a constant sodium intake using the lithium clearance as an index of fluid delivery to the distal tubule." | 3.68 | Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. ( Angeli, P; Caregaro, L; de Toni, R; Gatta, A; Menon, F; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D, 1990) |
"Human atrial natriuretic factor (ANF) levels were measured before and after peritoneovenous shunt implantation in 10 cirrhotic patients with ascites, in whom sodium retention is a major clinical problem." | 3.67 | Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation. ( Hartter, E; Klepetko, W; Miholics, J; Moeschl, P; Müller, C; Schwarz, C; Woloszczuk, W, 1988) |
"kg body wt for 45 min) of synthetic human atrial natriuretic factor (hANF) on renal hemodynamics and the renin-angiotensin-aldosterone system in 15 cirrhotic patients with ascites." | 3.67 | Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. ( Baldi, E; Cominelli, F; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E; Pinzani, M; Renzi, D, 1989) |
"Plasma levels of atrial natriuretic factor (ANP) were examined in 12 patients with liver cirrhosis (6 with ascites) and 6 controls before and after the administration of the infusion of 2000 ml of saline solution per 70 kg of body weight during 2 hours." | 3.67 | Atrial natriuretic factor in liver cirrhosis--the influence of volume expansion. ( Brodanová, M; Gregorová, I; Hirsa, M; Horký, K; Kordac, V; Kozáková, M; Petrýl, J; Tesar, V, 1989) |
"Plasma immunoreactive atrial natriuretic factor (irANF) levels and the effects of alpha-human ANF (alpha-hANF) infusion were investigated in 7 patients with liver cirrhosis and ascites." | 3.67 | Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. ( Beretta-Piccoli, C; Ferrier, C; Gnädinger, MP; Saxenhofer, H; Shaw, S; Suchecka-Rachon, K; Weidmann, P, 1989) |
"In order to evaluate the pathogenesis of the systemic hyperdynamic circulation in portal hypertension, serum concentration of eight kinds of hormones including glucagon (Glu), aldosterone (Ald), renin (Ren), and epinephrine (Adr), and the hemodynamic parameters were measured in a series of 30 patients, of whom 23 were patients with liver cirrhosis, 3 were with Banti's disease, 2 with chronic active hepatitis, and 2 with pre-cirrhotic change." | 3.67 | [Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension]. ( Ogata, T; Ohtsuka, H; Shima, S; Sugiura, Y; Tanaka, S; Yonekawa, H; Yoshizumi, Y, 1986) |
"Twenty patients with cirrhosis and ascites but no renal failure were given piretanide, a new loop diuretic, in order to investigate its efficacy and to relate the diuretic response with the pretreatment plasma aldosterone concentration." | 3.66 | Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level. ( Arroyo, V; Bosch, J; Cabrera, J; Casamitjana, R; Rivera, F; Rodés, J, 1980) |
"[1-Sarcosine, 8-Isoleucine] angiotensin II was given to 8 patients with cirrhosis and ascites and 7 cirrhotic patients without ascites on a regular diet." | 3.66 | Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites. ( Hata, T; Kumahara, Y; Mandai, T; Mikami, H; Nakamaru, M; Ogihara, T, 1979) |
"Plasma renin activity (PRA), plasma renin concentration (PRC), angiotensinogen, angiotensin II (AT II) and plasma aldosterone were determined by radioimmunoassay in 77 patients with cirrhosis of the liver [group I: with ascites, untreated (n=23); group II: patients with ascites during treatment (n=32); group III: after removal of fluids, but under further spironolactone therapy (n=10); group IV: untreated subjects without ascites (n=12)]." | 3.66 | Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver. ( Müller, G; Spech, HJ; Wernze, H, 1978) |
"Seven patients with persistent hyponatremia but normal or elevated serum arginine vasopressin levels and refractory ascites undergoing peritoneovenous shunting were studied in a Metabolic Unit on a 20 mEq sodium 1200 ml fluid-restricted diet to elucidate the mechanism of this response." | 3.66 | Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting. ( Blendis, LM; Langer, B; Reznick, RK; Seif, S; Taylor, BR, 1983) |
"Treatment with midodrine and albumin was associated with a slight but significant decrease in plasma renin activity and aldosterone compared to placebo (renin -4." | 2.87 | Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. ( Ariza, X; Castellote, J; Colmenero, J; Córdoba, J; de Prada, G; Fabrellas, N; Garcia-Martínez, R; Ginès, P; Graupera, I; Guevara, M; Huelin, P; Lopez Benaiges, E; Manríquez, M; Márquez, F; Martín-Llahí, M; Moreira, R; Navasa, M; Nazar, A; Pavesi, M; Pose, E; Simón-Talero, M; Solà, E; Solé, C; Suñé, P; Torrens, M; Vargas, V; Ventura, M; Xiol, X, 2018) |
"The acute effects of captopril in cirrhosis are well known but there are few descriptions of the pattern of response to chronic administration of captopril in this disease." | 2.67 | Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis. ( Afione, C; Arrizurieta, E; Barontini, M; Garzon, D; Ibarra, FR; Santos, JC, 1992) |
" Cardiac output and the gradient between wedged and free hepatic venous pressures significantly decreased after acute and chronic administration of propranolol; mean arterial pressure did not change significantly and systemic vascular resistance significantly increased." | 2.65 | Effects of propranolol on renal blood flow and renal function in patients with cirrhosis. ( Bataille, C; Bercoff, E; Lebrec, D; Pariente, EA; Valla, D, 1984) |
"In patients with congestive heart failure treated with digitalis, these natriuretic agents are particularly useful because of their potassium-sparing properties." | 2.37 | Clinical applications of antimineralocorticoids. ( Brunner, HR; Nüssberger, J; Waeber, B, 1988) |
"Liver cirrhosis is associated to circulatory abnormalities leading to hypovolemia and stimulation of the renin-angiotensin-aldosterone system (RAAS)." | 1.91 | Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression. ( Alvarez de la Rosa, D; González-Alayón, C; Hernández, G; Hernández-Guerra, M; Porrini, E; Rodríguez-Rodríguez, AE; Serrano-Morillas, N; Vastola-Mascolo, A, 2023) |
"Liver cirrhosis is a late-stage liver disease characterized by excessive fibrous deposition triggering portal-hypertension (PH); the prime restrainer for cirrhosis-related complications." | 1.72 | Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study. ( El-Banna, AA; El-Mezayen, NS; Ibrahim, RS, 2022) |
"Aldo promotes the activation of HSCs and liver fibrosis through NLRP3 inflammasome relative pathways." | 1.56 | Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome. ( Chen, T; Geng, S; Huang, Y; Li, X; Li, Y; Zhang, Y, 2020) |
"Primary and secondary hyperaldosteronism correlate with LV enlargement and high prevalence of LV hypertrophy and diastolic dysfunction; a subclinical systolic dysfunction is evident only in PA." | 1.43 | Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study. ( Angeli, P; Cesari, M; Letizia, C; Rosi, S; Rossi, GP; Sciomer, S, 2016) |
"Aldosterone is able to activate HSCs and increase PAI-1 expression during hepatic fibrosis, which may be inhibited by spironolactone." | 1.42 | Aldosterone and TGF-β₁ synergistically increase PAI-1 expression in hepatic stellate cells of rats. ( Gao, HJ; He, CZ; Wang, SL; Wu, HM; Yang, CQ; Yang, L, 2015) |
"Liver fibrosis was assessed by histology, Masson's trichrome staining, and the measurement of hydroxyproline and type I collagen content." | 1.38 | Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat. ( Cui, K; Huang, S; Ji, HL; Li, X; Luo, W; Meng, Y; Ni, SY; Pan, CQ; Xiao, LM; Yu, CH; Zhang, ZS, 2012) |
"Although non-alcoholic steatohepatitis (NASH) may progress to cirrhosis and hepatocellular carcinoma (HCC), no effective therapeutic modalities have been fully established yet." | 1.36 | Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats. ( Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Kawaratani, H; Kitade, M; Namisaki, T; Noguchi, R; Shirai, Y; Tsujimoto, T; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H, 2010) |
"Decompensated liver cirrhosis is characterized by activation of the renin-angiotensin-aldosterone system (RAAS)." | 1.35 | Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. ( Boomsma, F; Danser, AH; de Man, R; Kuiper, JJ; van Buren, H; van den Meiracker, AH, 2008) |
"Patients with liver cirrhosis and chronic heart failure (CHF) have a reduced capacity to excrete water." | 1.32 | Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. ( Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS, 2003) |
"It indicates that portal hypertension is an important factor in the genesis of cardiac dysfunction." | 1.32 | Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. ( Bandopadhyay, K; Biswas, PK; Das, D; Das, TK; Dasgupta, S; De, BK; Guru, S; Majumdar, D; Mandal, SK; Ray, S, 2003) |
"18 healthy subjects and 15 patients with liver cirrhosis were examined using a 2-hour method of passive leg rising (PLR)." | 1.31 | [Effect of passive leg lifting on sodium excretion in patients with liver cirrhosis]. ( Kovacova, A; Ladanyiova, D; Lazurova, I; Olexa, P; Ondic, O; Trejbal, D; Wagnerova, H, 2001) |
"In patients with liver cirrhosis and ascites, amino acid infusion improves kidney function." | 1.31 | Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites. ( Brensing, KA; Flommersfeld, S; Sauerbruch, T; Schiedermaier, P; Spengler, U; Stoffel-Wagner, B; Woitas, RP, 2002) |
"Patients with preascitic liver cirrhosis have an increased central plasma volume, and, for any given plasma aldosterone concentration, they excrete less sodium than healthy controls." | 1.30 | Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis. ( Baraldi, E; Castellana, CN; De Santis, MC; Ferrari, A; Manenti, F; Sansoè, G, 1999) |
"Ascites recurrence associated with shunt stenosis was observed during follow-up in eight patients; revision could be undertaken in five of them and resulted in good control of ascites." | 1.30 | Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution. ( Dufresne, MP; Fenyves, D; Lafortune, M; Legault, L; Martinet, JP; Pomier-Layrargues, G; Roy, L; Spahr, L, 1997) |
"The patients affected by liver cirrhosis without ascites showed PRA and PA levels similar to those observed in the control group, while ANP plasma levels were significantly higher (50." | 1.29 | [ANP in the cirrhotic patient. A clinical contribution]. ( Baccarini, S; Cervellini, P; Di Nardo, A; La Torre, F; Labellarte, A; Paparo, SB; Parlapiano, C; Primi, F, 1994) |
" These results show that long-term administration of spironolactone to patients with cirrhosis and no ascites produced a significant reduction in HVPG that may have been due to gradual, sustained volume contraction." | 1.29 | Plasma volume contraction in portal hypertension. ( Aramaki, T; Katsuta, Y; Okumura K [corrected to Okumura, H]; Okumura, H; Satomura, K; Sekiyama, T, 1993) |
"Substance P is a potent vasodilatory peptide produced by the enteric nervous system and partly cleared by the liver." | 1.29 | Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. ( Andrade, A; Fernández-Rodriguez, CM; Núñez, M; Penas, J; Prieto, J; Quiroga, J; Sangro, B; Zozoya, JM, 1995) |
" Aprotinin was infused intravenously in high dosage (2 x 10(6) kallikrein inhibitory units loading, 1 x 10(6) kallikrein inhibitory units/h)." | 1.29 | Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites. ( Craig, KJ; Cumming, AD; Hayes, PC; MacGilchrist, A, 1994) |
"Taurine is a non-protein sulfur amino acid widely distributed in mammalian tissues, with poorly understood functions." | 1.29 | Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites. ( Angelico, M; Bologna, E; Gentile, S; Terracina, D, 1994) |
"All of the patients had early-stage liver cirrhosis; according to Child's classification, nine patients had group A; three, group B cirrhosis." | 1.29 | The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children. ( Januszewicz, P; Socha, J; Warnawin, K; Winnicki, C, 1994) |
"In patients with liver cirrhosis a significant increase of diuresis and sodium diuresis took place, whilst the response was significant already in the first hour of WI." | 1.29 | [The effect of water immersion on humoral and urinary parameters in healthy persons and in patients with liver cirrhosis]. ( Fedorová, E; Hildebrand, T; Lazúrová, I; Lichardus, B; Luczy, J; Machánová, Y; Murár, J; Rosochová, I; Trejbal, D, 1994) |
"In 20 patients with advanced liver cirrhosis and ascites the aldosterone level in the blood plasma and in the ascitic fluid was higher than in the healthy controls." | 1.28 | [The clinical importance of determining aldosterone in the ascitic fluid]. ( Aleksiev, A; Konstantinova, N; Maleeva, A; Stanchev, N, 1990) |
"Twenty patients with liver cirrhosis and refractory ascites were studied before and during extraction-concentration-reinfusion (ECR) of ascitic fluid by means of Rhodiascit." | 1.28 | [Changes in antidiuretic hormone (ADH) in liver cirrhosis with resistant ascites]. ( Barbetti, V; Cattana, A; Colombo, P; Folco, U; Giudici Cipriani, A; Marenco, G; Menardo, G; Rembado, R, 1989) |
"It has been proposed that in liver cirrhosis portal hypertension causes splanchnic vasodilation and this induces blood volume expansion to maintain blood pressure." | 1.28 | Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis. ( Díez, J; Prieto, J; Simón, MA, 1991) |
"To 11 patients with liver cirrhosis (5 with ascites) and 6 controls a one-hour dopamine infusion, 1." | 1.28 | [The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis]. ( Gregorová, I; Horký, K; Jedlicka, J; Kopecká, J; Kordac, V; Marecek, Z; Marek, J; Petrtýl, J; Tesar, V, 1990) |
"Patients with marked edema due to congestive heart failure had plasma levels of atrial natriuretic factor five times higher than normal (P less than 0." | 1.27 | Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. ( Grekin, RJ; Ostafin, EA; Shenker, Y; Sider, RS, 1985) |
"Thirty-seven patients with liver cirrhosis (16 without ascites: group 1; 21 with untreated ascites at the first onset: group 2) were studied during controlled sodium intake (40 mmol/day)." | 1.27 | Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. ( Bernardi, M; De Palma, R; Gasbarrini, G; Santini, C; Trevisani, F, 1983) |
"Because hyponatremia is frequently associated with preceding diuretic treatment and unrestricted fluid intake--conditions which have not been addressed sufficiently in published literature--we studied the pathophysiology and the clinical setting of such hyponatremia in a large group of internal medicine patients." | 1.27 | Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. ( Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A, 1988) |
"Captopril caused an increase in plasma renin activity (p less than 0." | 1.27 | Effect of captopril on renin and blood pressure in cirrhosis. ( Renner, F; Sedlmayer, A; Silberbauer, K; Stanek, B, 1987) |
" The dosage of spironolactone needed to induce a negative sodium balance correlated significantly with plasma aldosterone concentration: r = 0." | 1.27 | Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. ( Bernardi, M; Gasbarrini, G; Rusticali, AG; Servadei, D; Trevisani, F, 1985) |
"Further volume expansion in liver cirrhosis by saline infusion led to the further increase in ANP (13." | 1.27 | Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis. ( Horký, K; Lachmanová, J; Srámková, J; Tesar, V; Widimský, J, 1988) |
"Secondary aldosteronism in connection with decompensated cirrhosis of the liver arises mainly under therapy with diuretics." | 1.26 | [What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?]. ( Albert, JP; Hartmann, F, 1981) |
" In normal subjects, Sar1-Ile-AII showed pressor (agonistic) activity, which was related to both dosage and sodium intake." | 1.26 | Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. ( Doi, K; Hata, T; Ichihara, K; Kumahara, Y; Ogihara, T; Yamamoto, T, 1976) |
"(4) Far above other mechanism hyperaldosteronism is most often induced by saluretic treatment of ascites and edema." | 1.26 | [Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy]. ( Spech, HJ, 1979) |
" In normotensives with normal plasma renin activity saralasine in the usual dosage (4." | 1.26 | [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)]. ( Dürr, H; Klaus, D; Lange, H; Witzgall, H; Zehner, J, 1976) |
" A simple clinical method using the urinary Na/K ratio as a guide to spironolactone dosage is outlined." | 1.25 | Spironolactone diuresis in patients with cirrhosis and ascites. ( Eggert, RC, 1970) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 248 (62.78) | 18.7374 |
1990's | 83 (21.01) | 18.2507 |
2000's | 41 (10.38) | 29.6817 |
2010's | 17 (4.30) | 24.3611 |
2020's | 6 (1.52) | 2.80 |
Authors | Studies |
---|---|
Schreier, B | 1 |
Zipprich, A | 1 |
Uhlenhaut, H | 1 |
Gekle, M | 1 |
Prasad, D | 1 |
Sen Sarma, M | 1 |
Yachha, SK | 1 |
Prasad, R | 1 |
Srivastava, A | 1 |
Poddar, U | 1 |
Kumar, A | 1 |
Ibrahim, RS | 1 |
El-Mezayen, NS | 1 |
El-Banna, AA | 1 |
Radwan, H | 1 |
Ibrahim, O | 1 |
Badra, G | 1 |
El-Said, H | 1 |
El-Haggar, S | 1 |
Serrano-Morillas, N | 1 |
González-Alayón, C | 1 |
Vastola-Mascolo, A | 1 |
Rodríguez-Rodríguez, AE | 1 |
Hernández, G | 1 |
Porrini, E | 1 |
Hernández-Guerra, M | 1 |
Alvarez de la Rosa, D | 1 |
Li, Y | 2 |
Zhang, Y | 2 |
Chen, T | 1 |
Huang, Y | 2 |
Geng, S | 1 |
Li, X | 4 |
Fialla, AD | 1 |
Thiesson, HC | 1 |
Bie, P | 1 |
Schaffalitzky de Muckadell, OB | 1 |
Krag, A | 1 |
Luo, X | 2 |
Zhu, X | 1 |
Wang, G | 1 |
Ning, Z | 1 |
Ma, X | 1 |
Yang, R | 1 |
Jin, S | 1 |
Meng, Y | 3 |
Solà, E | 2 |
Solé, C | 1 |
Simón-Talero, M | 1 |
Martín-Llahí, M | 1 |
Castellote, J | 1 |
Garcia-Martínez, R | 1 |
Moreira, R | 1 |
Torrens, M | 1 |
Márquez, F | 1 |
Fabrellas, N | 1 |
de Prada, G | 1 |
Huelin, P | 1 |
Lopez Benaiges, E | 1 |
Ventura, M | 1 |
Manríquez, M | 1 |
Nazar, A | 2 |
Ariza, X | 1 |
Suñé, P | 1 |
Graupera, I | 1 |
Pose, E | 1 |
Colmenero, J | 1 |
Pavesi, M | 2 |
Guevara, M | 4 |
Navasa, M | 1 |
Xiol, X | 1 |
Córdoba, J | 1 |
Vargas, V | 2 |
Ginès, P | 9 |
Hamdy, H | 1 |
ElBaz, AA | 1 |
Hassan, A | 1 |
Hassanin, O | 1 |
Jayakumar, S | 1 |
Carbonneau, M | 1 |
Hotte, N | 1 |
Befus, AD | 1 |
St Laurent, C | 1 |
Owen, R | 1 |
McCarthy, M | 1 |
Madsen, K | 2 |
Bailey, RJ | 1 |
Ma, M | 1 |
Bain, V | 1 |
Rioux, K | 1 |
Tandon, P | 2 |
Queisser, N | 1 |
Happ, K | 1 |
Link, S | 1 |
Jahn, D | 1 |
Zimnol, A | 1 |
Geier, A | 1 |
Schupp, N | 1 |
Wang, SL | 1 |
Wu, HM | 1 |
He, CZ | 1 |
Yang, L | 1 |
Gao, HJ | 1 |
Yang, CQ | 1 |
Tan, HK | 1 |
James, PD | 1 |
Wong, F | 10 |
Cesari, M | 1 |
Letizia, C | 1 |
Angeli, P | 5 |
Sciomer, S | 1 |
Rosi, S | 1 |
Rossi, GP | 1 |
Hanafy, AS | 1 |
Hassaneen, AM | 1 |
Kuiper, JJ | 1 |
Boomsma, F | 1 |
van Buren, H | 1 |
de Man, R | 1 |
Danser, AH | 1 |
van den Meiracker, AH | 1 |
Moncrief, K | 1 |
Arrieta, MC | 1 |
Owen, RJ | 1 |
Bain, VG | 1 |
Wong, WW | 1 |
Ma, MM | 1 |
Raina, N | 1 |
Richardson, R | 1 |
Sansoe, G | 7 |
Aragno, M | 1 |
Smedile, A | 3 |
Rizzetto, M | 3 |
Rosina, F | 4 |
Noguchi, R | 1 |
Yoshiji, H | 1 |
Ikenaka, Y | 1 |
Kaji, K | 1 |
Shirai, Y | 1 |
Aihara, Y | 1 |
Yamazaki, M | 1 |
Namisaki, T | 1 |
Kitade, M | 1 |
Yoshii, J | 1 |
Yanase, K | 1 |
Kawaratani, H | 1 |
Tsujimoto, T | 1 |
Fukui, H | 1 |
Romanelli, RG | 3 |
Laffi, G | 7 |
Vizzutti, F | 2 |
Del Bene, R | 2 |
Marra, F | 4 |
Caini, P | 1 |
Guerra, CT | 1 |
La Villa, G | 7 |
Barletta, G | 3 |
Montes-de-Oca, M | 1 |
Blanco, MJ | 1 |
Marquez, M | 1 |
Soto, MJ | 1 |
Fernandez-Gutiérrez, C | 1 |
Rodriguez-Ramos, C | 1 |
Giron-Gonzalez, JA | 1 |
Yang, YY | 1 |
Lin, HC | 2 |
Lin, MW | 1 |
Chu, CJ | 1 |
Lee, FY | 2 |
Hou, MC | 2 |
Lee, SD | 2 |
Lee, WP | 1 |
Liu, TT | 1 |
Jap, TS | 1 |
Luo, W | 1 |
Ji, HL | 1 |
Pan, CQ | 1 |
Huang, S | 1 |
Yu, CH | 1 |
Xiao, LM | 1 |
Cui, K | 1 |
Ni, SY | 1 |
Zhang, ZS | 2 |
Terra, C | 1 |
Fernández, J | 1 |
Arroyo, V | 15 |
Biava, AM | 1 |
Silvano, S | 3 |
Ferrari, A | 4 |
Touscoz, A | 1 |
Bonardi, L | 2 |
Woitas, RP | 2 |
Flommersfeld, S | 1 |
Stoffel-Wagner, B | 2 |
Schiedermaier, P | 1 |
Brensing, KA | 1 |
Spengler, U | 2 |
Sauerbruch, T | 4 |
Blei, AT | 1 |
Blendis, LM | 11 |
Thuluvath, PJ | 1 |
Caligiuri, A | 1 |
De Franco, RM | 1 |
Gentilini, A | 1 |
Meucci, M | 1 |
Failli, P | 1 |
Mazzetti, L | 1 |
Rombouts, K | 1 |
Geerts, A | 1 |
Vanasia, M | 1 |
Gentilini, P | 7 |
Pinzani, M | 3 |
Pedersen, RS | 1 |
Bentzen, H | 1 |
Bech, JN | 1 |
Nyvad, O | 1 |
Pedersen, EB | 3 |
Brinch, K | 1 |
Møller, S | 1 |
Bendtsen, F | 1 |
Becker, U | 1 |
Henriksen, JH | 2 |
De, BK | 1 |
Majumdar, D | 1 |
Das, D | 1 |
Biswas, PK | 1 |
Mandal, SK | 1 |
Ray, S | 1 |
Bandopadhyay, K | 1 |
Das, TK | 1 |
Dasgupta, S | 1 |
Guru, S | 1 |
WOLFF, HP | 8 |
KOCZOREK, KR | 1 |
BEAULIEU, EE | 2 |
FUNEL, P | 2 |
LEMONNIER, F | 2 |
VESIN, P | 2 |
SUMMERSKILL, WH | 3 |
CRABBE, J | 2 |
DYRENFURTH, I | 1 |
STACEY, CH | 1 |
BECK, JC | 1 |
VENNING, EH | 1 |
WESSON, LG | 1 |
SUNSHINE, A | 1 |
EPSTEIN, JA | 1 |
KERR, DN | 1 |
READ, AE | 1 |
HASLAM, RM | 1 |
SHERLOCK, S | 1 |
OLIVER, E | 1 |
RAIMONDI, A | 1 |
BRUNO, V | 1 |
STORMONT, JM | 1 |
FAST, B | 1 |
WOLFE, SJ | 1 |
DAVIDSON, CS | 1 |
ETIENNE-MARTIN, P | 1 |
KLEPPING, C | 1 |
GUERRIN, J | 1 |
FLANDRIN, P | 1 |
GROULADE, J | 1 |
HOLLARD, D | 1 |
RACHAIL, M | 1 |
GIRARD, M | 1 |
BEL, A | 1 |
GUILLERMET, J | 1 |
MICHEL, J | 1 |
BOTHIER, F | 1 |
HEMPEL-JORGENSEN, P | 3 |
EILERSEN, P | 3 |
HOLUB, DA | 1 |
JAILER, JW | 1 |
MULLER, B | 1 |
EMIN, R | 1 |
BONCOMPAIN, J | 1 |
OGDEN, DA | 1 |
SCHERR, L | 1 |
SPRITZ, N | 1 |
RUBIN, AL | 1 |
PERRINI, M | 1 |
PILIEGO, N | 2 |
RICCIARDI, G | 1 |
PINTO, I | 1 |
LEVRAT, M | 1 |
BRETTE, R | 1 |
FRANCOIS, B | 1 |
TISSOT, A | 1 |
MESTRALLET, G | 1 |
LOCKWOOD, CH | 1 |
MALLEIN, R | 1 |
BESSET, C | 2 |
OLIVIER, L | 1 |
VACHON, A | 2 |
MORRISON, RS | 2 |
CHALMERS, TC | 1 |
THOMAS, JP | 1 |
BARTTER, FC | 1 |
ARCADIO, F | 1 |
JOUD, R | 1 |
JUSTIN-BESANCON, L | 2 |
LAROCHE, C | 2 |
NENNA, A | 2 |
ETIENNE, JP | 2 |
CREMER, G | 2 |
FRANKEN, FH | 1 |
IRMSCHER, K | 1 |
VELASCO, M | 2 |
KATZ, R | 2 |
KATZ, E | 1 |
GARCIA, H | 1 |
GAZMURI, R | 2 |
ALBAHARY, C | 1 |
POMMEY, B | 1 |
BLATT, B | 1 |
BONINI, A | 1 |
CHEY, WY | 1 |
SHAY, H | 1 |
COPPAGE, WS | 1 |
ISLAND, DP | 1 |
COONER, AE | 1 |
LIDDLE, GW | 1 |
van DOMMELEN, C | 1 |
LE POOLE, A | 1 |
VAANDRAGER, H | 1 |
SCHOPMAN, W | 1 |
WADMAN, SK | 1 |
CLOWDUS, BF | 1 |
ROSEVEAR, JW | 1 |
TORBICA, MM | 1 |
ANICHINI, M | 1 |
GARGANO, N | 1 |
BARTORELLI, C | 1 |
DE MARTINIS, C | 2 |
FONZO, D | 1 |
PUPITA, F | 1 |
MENSA, R | 1 |
RIVERA, A | 1 |
SEPULVEDA, B | 1 |
LANDA, L | 1 |
CHAGOYA, L | 1 |
LUETSCHER, JA | 1 |
CAMARGO, CA | 1 |
COHN, AP | 1 |
DOWDY, AJ | 1 |
CALLAGHAN, AM | 1 |
GOMEZ, RE | 1 |
PRIETO, ME | 1 |
DOMINGUEZ, JP | 1 |
GENERINI, G | 1 |
MANZO, S | 1 |
RUBEGNI, M | 1 |
RAVENNI, G | 1 |
FORCONI, S | 1 |
KNEZEVIC, S | 1 |
HAHN, A | 1 |
BROWN, JJ | 1 |
DAVIES, DL | 1 |
LEVER, AF | 1 |
ROBERTSON, JI | 1 |
ROSSINI, P | 1 |
DELZOTTI, G | 1 |
CURCIO, R | 1 |
CASSIA, B | 1 |
TORIKAI, T | 1 |
FUKUCHI, S | 1 |
HANATA, M | 1 |
TAKAHASHI, H | 2 |
DEMURA, H | 1 |
DAVIS, JO | 1 |
HOFFMEISTER, W | 1 |
ARGUEELLES, AE | 1 |
CHEKHERDEMIAN, M | 1 |
MUNIAGURRIA, JL | 1 |
RICCA, A | 1 |
ORLOFF, MJ | 1 |
ROSS, TH | 1 |
BADDELEY, RM | 1 |
NUTTING, RO | 1 |
SPITZ, BR | 1 |
SLOOP, RD | 1 |
NEESBY, T | 1 |
HALASZ, NA | 1 |
PETERMANN, CP | 1 |
FRANCE, CJ | 1 |
COOPER, RR | 1 |
BIGLIERI, EG | 1 |
SLATON, PE | 1 |
JACONO, A | 1 |
BUONINCONTI, R | 1 |
VITALE, P | 1 |
WAHI, PN | 3 |
BODKHE, RR | 3 |
WAHAL, PK | 3 |
MIYAKE, T | 1 |
HORKY, K | 8 |
KUECHEL, O | 1 |
PAZOUREK, M | 1 |
BANSAL, OP | 1 |
LAHIRI, B | 1 |
LOMMER, D | 4 |
TORBICA, M | 1 |
AMES, RP | 1 |
BORKOWSKI, AJ | 1 |
SICINSKI, AM | 1 |
LARAGH, JH | 2 |
PLAYOUST, MR | 1 |
BLACKBURN, CR | 1 |
LEPPLA, W | 1 |
TIEFENSEE, H | 1 |
MINICONI, P | 2 |
OFSTAD, J | 1 |
SIGSTAD, H | 1 |
PAGET, M | 1 |
LANGERON, L | 1 |
CROCCEL, L | 1 |
ROUTIER, G | 1 |
CROCCEL, E | 1 |
PROTIN, M | 1 |
Kotzampassi, K | 1 |
Metaxas, G | 1 |
Paramythiotis, D | 1 |
Pidonia, I | 1 |
Rekka, H | 1 |
Karamouzis, M | 1 |
Eleftheriadis, E | 1 |
Graebe, M | 1 |
Brond, L | 1 |
Christensen, S | 1 |
Nielsen, S | 1 |
Olsen, NV | 1 |
Jonassen, TE | 1 |
Yao, JF | 1 |
Yao, XX | 1 |
Fang, HM | 1 |
Cui, DL | 1 |
Bai, WY | 1 |
Magni, P | 1 |
Motta, M | 1 |
Wickert, L | 1 |
Abiaka, M | 1 |
Bolkenius, U | 1 |
Gressner, AM | 1 |
Wang, L | 1 |
Liu, HL | 1 |
Huang, X | 1 |
Zhu, G | 1 |
Coll, S | 4 |
Vila, MC | 4 |
Molina, L | 2 |
Gimenez, MD | 1 |
Guarner, C | 3 |
Solà, R | 4 |
Gu, XB | 1 |
Chen, HK | 1 |
Zhu, YF | 1 |
Pei, H | 1 |
Liu, XY | 1 |
Pantea, L | 1 |
Sniderman, K | 1 |
Jiang, B | 1 |
Yang, XS | 1 |
Wang, WW | 1 |
Guo, D | 1 |
Lai, ZS | 1 |
Singh, V | 2 |
Kumar, R | 1 |
Nain, CK | 2 |
Singh, B | 2 |
Sharma, AK | 2 |
Kalambokis, G | 1 |
Economou, M | 1 |
Kosta, P | 1 |
Papadimitriou, K | 1 |
Tsianos, EV | 1 |
Kumar, B | 1 |
Sharma, N | 1 |
Bhalla, A | 1 |
Schrier, RW | 5 |
Fierbinteanu-Braticevici, C | 1 |
Dragomir, P | 1 |
Tribus, L | 1 |
Negreanu, L | 1 |
Bengus, A | 1 |
Usvat, R | 1 |
Andronescu, D | 1 |
Carstens, J | 1 |
Grønbaek, H | 1 |
Larsen, HK | 1 |
Vilstrup, H | 1 |
El-Ashry, N | 1 |
El-Damarawy, M | 1 |
Salem, M | 1 |
Mogawer, S | 1 |
Appenrodt, B | 1 |
Wolf, A | 1 |
Grünhage, F | 1 |
Trebicka, J | 1 |
Schepke, M | 1 |
Rabe, C | 1 |
Lammert, F | 1 |
Heller, J | 4 |
Sprintsson, RG | 1 |
Witte, MH | 2 |
Levine, N | 1 |
Dumont, AE | 1 |
Hirano, Y | 1 |
Ichikawa, S | 1 |
Reznick, RK | 1 |
Langer, B | 2 |
Taylor, BR | 2 |
Seif, S | 1 |
Sicuteri, F | 1 |
Smorlesi, C | 2 |
Del Bianco, PL | 1 |
Fanciullacci, M | 1 |
Curradi, C | 1 |
Bernardi, M | 15 |
Trevisani, F | 13 |
Santini, C | 4 |
De Palma, R | 5 |
Gasbarrini, G | 13 |
Santucci, A | 2 |
Aguglia, F | 2 |
Violi, F | 2 |
De Mattia, G | 2 |
Cammarella, I | 2 |
Giordano, M | 2 |
Trinchieri, F | 2 |
Gnecchi, M | 2 |
Bataille, C | 1 |
Bercoff, E | 1 |
Pariente, EA | 1 |
Valla, D | 3 |
Lebrec, D | 5 |
Chmielewska, J | 1 |
Mysliwiec, M | 1 |
Myśliwiec, B | 1 |
Hattori, K | 1 |
Hasumura, Y | 1 |
Takeuchi, J | 1 |
Servadei, D | 2 |
Rosin, IuA | 1 |
Pampana, A | 1 |
Mannelli, M | 1 |
Sewell, RB | 1 |
Poston, L | 1 |
Wilkinson, SP | 7 |
Bichet, DG | 1 |
Van Putten, VJ | 1 |
Tang, ZD | 1 |
Bosch, J | 8 |
Mauri, M | 3 |
Ribera, F | 1 |
Navarro-López, F | 1 |
Rodés, J | 11 |
Sellars, L | 2 |
Shore, AC | 2 |
Wilkinson, R | 2 |
James, OF | 1 |
Robson, V | 1 |
Kuntz, E | 1 |
Anderson, GH | 2 |
Anderson, T | 1 |
Streeten, DH | 2 |
Schroeder, ET | 2 |
Martin, A | 1 |
Sturniolo, GC | 1 |
Naccarato, R | 1 |
Williams, R | 5 |
Gaya-Beltrán, J | 1 |
Kravetz, D | 1 |
Estrada, L | 1 |
Rivera, F | 7 |
Porush, JG | 1 |
Chou, SY | 1 |
Wheeler, PG | 1 |
Jowett, TP | 3 |
Smith, IK | 2 |
Keenan, J | 1 |
Slater, JD | 4 |
Skorecki, KL | 6 |
Brenner, BM | 1 |
Pini, P | 1 |
Turci, P | 1 |
Albert, JP | 2 |
Hartmann, F | 2 |
Casamitjana, R | 1 |
Cabrera, J | 1 |
Tsykin, DB | 1 |
Iampol'skaia, LI | 1 |
Borisov, AE | 1 |
Tsykina, GA | 1 |
Shcherba, IuV | 1 |
Oktiabr'skaia, IN | 1 |
Levina, AE | 1 |
Andreu, M | 3 |
Oliver, MI | 1 |
Gana, J | 3 |
Ledesma, S | 1 |
Jiménez, W | 7 |
MacGilchrist, A | 1 |
Craig, KJ | 1 |
Hayes, PC | 1 |
Cumming, AD | 1 |
Fernández-Rodriguez, CM | 2 |
Prieto, J | 6 |
Quiroga, J | 4 |
Zozoya, JM | 1 |
Andrade, A | 1 |
Núñez, M | 1 |
Sangro, B | 1 |
Penas, J | 1 |
Albillos, A | 1 |
Lledó, JL | 1 |
Rossi, I | 1 |
Pérez-Páramo, M | 1 |
Tabuenca, MJ | 1 |
Bañares, R | 1 |
Iborra, J | 1 |
Garrido, A | 1 |
Escartín, P | 1 |
Jespersen, B | 1 |
Eiskjaer, H | 1 |
Jensen, JD | 1 |
Mogensen, CE | 1 |
Sørensen, SS | 1 |
Colantoni, A | 1 |
Sica, G | 1 |
Gasbarrini, A | 4 |
D'Intino, PE | 1 |
De Notariis, S | 1 |
De Jaso, R | 1 |
Barbieri, A | 1 |
Morselli, A | 1 |
Saló, J | 3 |
Ginès, A | 5 |
Anibarro, L | 1 |
Bataller, R | 2 |
Clària, J | 4 |
Fornalè, L | 2 |
Di Marco, C | 2 |
Baraldini, M | 7 |
Ligabue, A | 5 |
Parlapiano, C | 1 |
Labellarte, A | 1 |
Primi, F | 1 |
Cervellini, P | 1 |
La Torre, F | 1 |
Paparo, SB | 1 |
Baccarini, S | 1 |
Di Nardo, A | 1 |
Winnicki, C | 1 |
Warnawin, K | 1 |
Januszewicz, P | 1 |
Socha, J | 1 |
Lazúrová, I | 3 |
Lichardus, B | 2 |
Luczy, J | 1 |
Rosochová, I | 2 |
Trejbal, D | 3 |
Machánová, Y | 2 |
Hildebrand, T | 2 |
Fedorová, E | 1 |
Murár, J | 2 |
Morillas, RM | 1 |
Planas, R | 3 |
Cabré, E | 1 |
Galán, A | 1 |
Quer, JC | 1 |
Feu, F | 3 |
García Pagán, JC | 1 |
Gassull, MA | 1 |
Rimondi, A | 1 |
Caraceni, P | 1 |
Legnani, C | 1 |
Palareti, G | 1 |
Pozzi, M | 1 |
Osculati, G | 1 |
Boari, G | 1 |
Serboli, P | 1 |
Colombo, P | 2 |
Lambrughi, C | 1 |
De Ceglia, S | 1 |
Roffi, L | 1 |
Piperno, A | 1 |
Cusa, EN | 1 |
Tesar, V | 7 |
Spicák, J | 1 |
Zabka, J | 1 |
Widimský, J | 2 |
Jedlicka, J | 2 |
Marecek, Z | 2 |
Kee, CS | 1 |
Choi, JW | 1 |
Chang, DK | 1 |
Ahn, YH | 1 |
Kim, HJ | 1 |
Gentile, S | 3 |
Bologna, E | 2 |
Terracina, D | 1 |
Angelico, M | 3 |
Seino, Y | 1 |
Ohki, K | 1 |
Nakamura, T | 1 |
Tsukamoto, H | 1 |
Takano, T | 1 |
Aramaki, T | 2 |
Okumura, H | 2 |
Hayakawa, H | 1 |
García-Compeán, D | 1 |
Zacarías Villarreal, J | 1 |
Bahena Cuevas, H | 1 |
García Cantú, DA | 1 |
Estrella, M | 1 |
Garza Tamez, E | 1 |
Valadez Castillo, R | 1 |
Barragán, RF | 1 |
Dalla Pria, M | 1 |
De Bei, E | 1 |
Albino, G | 1 |
Caregaro, L | 3 |
Merkel, C | 3 |
Ceolotto, G | 1 |
Gatta, A | 3 |
Liu, P | 3 |
Tobe, S | 3 |
Morali, G | 1 |
Blendis, L | 3 |
Legault, L | 4 |
Warner, LC | 2 |
Leung, WM | 3 |
Logan, AG | 5 |
Skorecki, K | 1 |
Messa, P | 1 |
Cannella, G | 1 |
Mioni, G | 1 |
Boscutti, G | 1 |
Messa, M | 1 |
De Biasi, F | 1 |
Cioni, A | 1 |
Zozaya, JM | 3 |
Guitián, R | 1 |
Salmerón, JM | 2 |
Ruiz del Arbol, L | 1 |
García-Pagán, JC | 1 |
Katsuta, Y | 1 |
Sekiyama, T | 1 |
Satomura, K | 1 |
Okumura K [corrected to Okumura, H] | 1 |
Andreone, P | 2 |
Cursaro, C | 3 |
Tamè, MR | 2 |
Shirakami, G | 1 |
Murakawa, M | 1 |
Shingu, K | 1 |
Mashima, S | 1 |
Suga, S | 1 |
Magaribuchi, T | 1 |
O'higashi, T | 1 |
Shichino, T | 1 |
Nakao, K | 1 |
Mori, K | 1 |
Tkác, I | 1 |
Yokoyama, M | 1 |
Shijo, H | 1 |
Ota, K | 1 |
Kubara, K | 1 |
Kokawa, H | 1 |
Kim, T | 1 |
Akiyoshi, N | 1 |
Okumura, M | 1 |
Inoue, K | 1 |
Gülberg, V | 1 |
Gerbes, AL | 2 |
Tsai, YT | 1 |
Wang, SS | 1 |
Kuhn, M | 1 |
Fernández-Esparrach, G | 3 |
Forssmann, WG | 1 |
Martinet, JP | 1 |
Fenyves, D | 2 |
Roy, L | 2 |
Dufresne, MP | 2 |
Spahr, L | 2 |
Lafortune, M | 2 |
Pomier-Layrargues, G | 2 |
Pasqualetti, P | 4 |
Festuccia, V | 1 |
Collacciani, A | 1 |
Di Lauro, G | 1 |
Casale, R | 4 |
Peltekian, KM | 1 |
Liu, PP | 1 |
Sherman, M | 1 |
Sort, P | 2 |
Pardo, A | 1 |
Geuvel, A | 1 |
Elewaut, A | 1 |
Adler, M | 1 |
Lazzeri, C | 1 |
Pascale, A | 1 |
Sestini, S | 1 |
Bisi, G | 1 |
Sciagrà, R | 1 |
Vecchiarino, S | 2 |
Raggi, VC | 1 |
Ruiz-del-Arbol, L | 1 |
Monescillo, A | 1 |
Garcia-Plaza, A | 2 |
Cirera, I | 1 |
Elizalde, JI | 1 |
Piqué, JM | 1 |
Casadevall, M | 1 |
Goldin, E | 1 |
Terés, J | 1 |
Fábrega, E | 1 |
Casafont, F | 1 |
Crespo, J | 1 |
de la Peña, J | 1 |
San Miguel, G | 1 |
de las Heras, G | 1 |
García-Unzueta, MT | 1 |
Amado, JA | 1 |
Pons-Romero, F | 1 |
Baraldi, E | 3 |
Grisolia, C | 1 |
De Santis, MC | 2 |
Villa, E | 1 |
Manenti, F | 3 |
Lefebvre, H | 1 |
Héron, F | 1 |
Contesse, V | 1 |
Delarue, C | 1 |
Vaudry, H | 1 |
Kuhn, JM | 1 |
Marquez, J | 2 |
Palá, J | 1 |
Bory, F | 1 |
Pons, S | 1 |
Szescielinski, L | 1 |
Sàbat, M | 1 |
Soriano, G | 1 |
Bulbena, O | 1 |
Novella, MT | 1 |
Ortiz, J | 1 |
Ricart, E | 1 |
Villanueva, C | 1 |
Rosello, J | 1 |
Rodríguez, J | 1 |
Balanzó, J | 1 |
Veglio, F | 2 |
Melchio, R | 2 |
Calva, S | 1 |
Rabbia, F | 2 |
Gallo, V | 1 |
Molino, P | 1 |
Mengozzi, G | 1 |
Mulatero, P | 1 |
Martini, G | 1 |
Riva, P | 1 |
Chiandussi, L | 2 |
Genesca, J | 1 |
Gonzalez, A | 1 |
Segura, R | 1 |
Catalan, R | 1 |
Marti, R | 1 |
Varela, E | 1 |
Cadelina, G | 1 |
Martinez, M | 1 |
Lopez-Talavera, JC | 1 |
Esteban, R | 1 |
Groszmann, RJ | 1 |
Guardia, J | 1 |
Deschênes, M | 1 |
Bui, B | 1 |
Palmer, BF | 1 |
Gadano, A | 1 |
Moreau, R | 3 |
Chagneau, C | 2 |
Vachiéry, F | 1 |
Trombino, C | 1 |
Elman, A | 1 |
Denié, C | 1 |
Castellana, CN | 2 |
Iwao, T | 1 |
Oho, K | 1 |
Nakano, R | 1 |
Sakai, T | 1 |
Sato, M | 1 |
Miyamoto, Y | 1 |
Kumamoto, M | 1 |
Sakai, K | 1 |
Sata, M | 1 |
Toyonaga, A | 1 |
Knotek, M | 1 |
Rogachev, B | 1 |
DeGasperi, A | 1 |
Cristalli, A | 1 |
Corti, A | 1 |
Fantini, G | 1 |
Colussi, G | 1 |
Prosperi, M | 1 |
Sabbadini, D | 1 |
DeCarlis, L | 1 |
Mazza, E | 1 |
Scaiola, A | 1 |
Pannacciulli, E | 1 |
Savi, MC | 1 |
Amici, O | 1 |
Vai, S | 1 |
Colle, I | 1 |
Pessione, F | 1 |
Rassiat, E | 1 |
Pateron, D | 1 |
Barrière, E | 1 |
Condat, B | 1 |
Sogni, P | 1 |
Magri, P | 1 |
Auletta, M | 1 |
Andreucci, M | 1 |
Somma, G | 1 |
Musone, D | 1 |
Fiorillo, M | 1 |
Torraca, S | 1 |
Antoniello, S | 1 |
Cianciaruso, B | 1 |
Lenaerts, A | 1 |
Codden, T | 1 |
Henry, JP | 1 |
Van Cauter, J | 1 |
Meunier, JC | 1 |
Ligny, G | 1 |
Pantaleo, P | 1 |
Masini, E | 1 |
Perfetto, F | 1 |
Tarquini, R | 1 |
Wagnerova, H | 1 |
Ladanyiova, D | 1 |
Ondic, O | 1 |
Olexa, P | 1 |
Kovacova, A | 1 |
Biava, A | 1 |
Viver, J | 1 |
Mas, A | 1 |
Kley, HK | 1 |
Krüskemper, HL | 1 |
Epstein, M | 4 |
Fiordalisi, HH | 1 |
Mamianetti, A | 1 |
Greig, PD | 1 |
Baigrie, RS | 1 |
Ruse, J | 1 |
Hata, T | 2 |
Ogihara, T | 2 |
Mikami, H | 1 |
Nakamaru, M | 1 |
Mandai, T | 1 |
Kumahara, Y | 2 |
Spech, HJ | 4 |
García Puig, J | 1 |
Gancedo González, P | 1 |
Mateos Antón, F | 1 |
Herrero Huerta, E | 1 |
Muro González, J | 1 |
Ortíz Vázquez, J | 1 |
Moodie, H | 1 |
Wronski, R | 1 |
Jentzen, F | 1 |
Shohat, J | 1 |
Iaina, A | 1 |
Serban, I | 1 |
Theodor, E | 1 |
Eliahou, HE | 1 |
Wapnick, S | 1 |
Grosberg, S | 1 |
Kinney, M | 1 |
LeVeen, HH | 1 |
Witte, CL | 1 |
Jacobs, S | 1 |
Kut, R | 1 |
Barratt, LJ | 1 |
Chonko, AM | 2 |
Bay, WH | 1 |
Stein, JH | 2 |
Ferris, TF | 2 |
Wernze, H | 5 |
Müller, G | 2 |
Bosch, Y | 1 |
Saito, I | 1 |
Saruta, T | 1 |
Eguchi, T | 1 |
Nakamura, R | 1 |
Kondo, K | 1 |
Iyori, S | 1 |
Kato, E | 2 |
Levy, M | 1 |
Levinson, R | 2 |
Sancho, J | 1 |
Haber, E | 1 |
Re, R | 1 |
Vetter, H | 1 |
Vetter, W | 1 |
Beckerhoff, R | 1 |
Glänzer, K | 1 |
Furrer, J | 1 |
Hahn, C | 1 |
Kolloch, R | 1 |
Krück, F | 2 |
Kutz, K | 1 |
Siegenthaler, W | 1 |
Witassek, F | 1 |
Goldman, SH | 1 |
Thiele, KG | 1 |
Klaus, D | 1 |
Witzgall, H | 1 |
Zehner, J | 1 |
Dürr, H | 1 |
Lange, H | 1 |
Mulrow, PJ | 1 |
Noth, R | 1 |
Yamamoto, T | 1 |
Doi, K | 1 |
Ichihara, K | 1 |
Wellhöfer, G | 1 |
Hilfenhaus, M | 1 |
Deeg, P | 1 |
Rosoff, L | 1 |
Zia, P | 1 |
Reynolds, T | 1 |
Horton, R | 2 |
Salvetti, A | 1 |
Acquaviva, G | 1 |
Sassano, P | 1 |
Arzilli, F | 1 |
Pins, DS | 1 |
Schneider, N | 1 |
van Vliet, AA | 1 |
Hackeng, WH | 1 |
Donker, AJ | 1 |
Meuwissen, SG | 1 |
Brenard, R | 1 |
Pussard, E | 1 |
Champigneulle, B | 1 |
Gaudin, C | 1 |
Hadengue, A | 1 |
Braillon, A | 1 |
Pinna, G | 1 |
Panarelli, M | 1 |
Gagliardi, B | 1 |
Ibarra, FR | 1 |
Afione, C | 1 |
Garzon, D | 1 |
Barontini, M | 1 |
Santos, JC | 1 |
Arrizurieta, E | 1 |
Giancane, S | 1 |
Panos, MZ | 1 |
Anderson, JV | 1 |
Payne, N | 1 |
Langley, P | 1 |
Rees, L | 1 |
Uchihara, M | 1 |
Izumi, N | 1 |
Sato, C | 1 |
Marumo, F | 1 |
Morali, GA | 2 |
Tobe, SW | 1 |
Casini Raggi, V | 1 |
Tosti-Guerra, C | 1 |
De Feo, ML | 1 |
Llach, J | 1 |
Panés, J | 1 |
Toledo, C | 1 |
Rimola, A | 1 |
Salerno, F | 3 |
Badalamenti, S | 3 |
Lorenzano, E | 3 |
Moser, P | 2 |
Incerti, P | 3 |
Tözün, N | 1 |
Berkman, K | 1 |
Tankurt, E | 1 |
Kalayci, C | 1 |
Ozdogan, O | 1 |
Aran, S | 1 |
Taga, Y | 1 |
Habib, YA | 1 |
Kira, LH | 1 |
el-Sherbini, HA | 1 |
Asser, LA | 1 |
el-Shamy, EA | 1 |
Hatem, YA | 1 |
Floras, JS | 1 |
Dussaule, JC | 1 |
Grangé, JD | 1 |
Wolf, JP | 1 |
Lecomte, JM | 1 |
Gros, C | 1 |
Schwartz, JC | 1 |
Bodin, F | 1 |
Ardaillou, R | 1 |
Menon, F | 2 |
Sacerdoti, D | 2 |
Simón, MA | 1 |
Díez, J | 1 |
Leehey, DJ | 1 |
Gollapudi, P | 1 |
Deakin, A | 1 |
Reid, RW | 1 |
Graziani, G | 1 |
Morganti, A | 1 |
Ghirardi, P | 1 |
Zhang, JF | 1 |
Maleeva, A | 1 |
Stanchev, N | 1 |
Konstantinova, N | 1 |
Aleksiev, A | 1 |
Rondana, M | 1 |
de Toni, R | 1 |
Ruol, A | 1 |
Dioguardi, N | 1 |
Petrtýl, J | 3 |
Gregorová, I | 4 |
Kopecká, J | 1 |
Marek, J | 1 |
Kordac, V | 4 |
Srámková, J | 2 |
Dvoráková, J | 1 |
Ohnishi, A | 1 |
Ishizaki, T | 1 |
Murakami, S | 1 |
Tanaka, T | 1 |
Colantonio, D | 3 |
Natali, G | 3 |
Desiati, P | 3 |
Arendt, RM | 1 |
Riedel, A | 1 |
Paumgartner, G | 1 |
Kozáková, M | 3 |
Plouin, PF | 1 |
Chatellier, G | 1 |
Guyene, TT | 1 |
Vincent, N | 1 |
Corvol, P | 1 |
Giandomenico, G | 2 |
Ferrier, C | 1 |
Beretta-Piccoli, C | 1 |
Weidmann, P | 1 |
Gnädinger, MP | 1 |
Shaw, S | 1 |
Suchecka-Rachon, K | 1 |
Saxenhofer, H | 1 |
Petrýl, J | 1 |
Brodanová, M | 2 |
Hirsa, M | 1 |
Meacci, E | 1 |
Renzi, D | 1 |
Baldi, E | 1 |
Cominelli, F | 1 |
Tsai, HH | 1 |
Lees, KR | 1 |
Howden, CW | 1 |
Reid, JL | 1 |
Dustov, AD | 2 |
Capocaccia, L | 1 |
Fernandez-Seara, J | 1 |
Cobos, MA | 1 |
Rodriguez-Eire, JL | 1 |
Leal, J | 1 |
Cosby, RL | 1 |
Yee, B | 1 |
Marenco, G | 1 |
Giudici Cipriani, A | 2 |
Folco, U | 1 |
Menardo, G | 1 |
Cattana, A | 1 |
Barbetti, V | 1 |
Rembado, R | 1 |
Mansurov, KhKh | 1 |
Nikolaeva, OS | 1 |
Aliaga, L | 1 |
Richter, JA | 1 |
Campbell, P | 1 |
Wong, PY | 1 |
Bull, S | 1 |
Pancione, L | 1 |
Capani, F | 2 |
Shenker, Y | 1 |
Sider, RS | 1 |
Ostafin, EA | 1 |
Grekin, RJ | 1 |
Klepetko, W | 1 |
Müller, C | 1 |
Hartter, E | 1 |
Miholics, J | 1 |
Schwarz, C | 1 |
Woloszczuk, W | 1 |
Moeschl, P | 1 |
Burghardt, W | 1 |
Müller, R | 1 |
Diehl, KL | 1 |
Lachmanová, J | 1 |
Jirsa, M | 1 |
Campbell, PJ | 1 |
Debowski, TE | 1 |
Tiberio López, G | 1 |
Tanco, S | 1 |
Orradre, B | 1 |
Berrade, MF | 1 |
Anderiz López, M | 1 |
Kawasaki, H | 2 |
Uemasu, J | 1 |
Maeda, N | 1 |
Hirayama, C | 2 |
Kobayashi, T | 2 |
Sakurai, H | 1 |
Loginov, AS | 3 |
Khodarev, NN | 1 |
Astaf'eva, OV | 1 |
Ikebe, H | 1 |
Hoashi, S | 1 |
Irie, F | 1 |
Taniguchi, K | 1 |
Honda, N | 1 |
Mitarai, Y | 1 |
Kobayashi, N | 1 |
Gross, P | 1 |
Ketteler, M | 1 |
Hausmann, C | 1 |
Reinhard, C | 1 |
Schömig, A | 1 |
Hackenthal, E | 1 |
Ritz, E | 1 |
Rascher, W | 1 |
Emili, M | 1 |
Cuppone, R | 1 |
Ricci, GL | 1 |
Waeber, B | 1 |
Nüssberger, J | 1 |
Brunner, HR | 1 |
Ring-Larsen, H | 1 |
Wilken, C | 1 |
Clausen, J | 1 |
Pals, H | 1 |
Christensen, NJ | 1 |
Miyamori, I | 1 |
Koshida, H | 1 |
Matsubara, T | 1 |
Ikeda, M | 1 |
Takeda, Y | 1 |
Takeda, R | 1 |
Vecsei, P | 3 |
Stanek, B | 1 |
Renner, F | 1 |
Sedlmayer, A | 1 |
Silberbauer, K | 1 |
Malatesta, R | 1 |
Murawaki, Y | 1 |
Amerio, A | 1 |
Cananzi, C | 1 |
Zanelli, G | 1 |
Zinicola, N | 1 |
Colina, I | 1 |
Guarner, F | 1 |
Corzo, J | 1 |
Vilardell, F | 1 |
Ostolaza Vázquez, JM | 1 |
Jimeno Carruez, A | 1 |
Lapeña Villarroyo, G | 1 |
Vallecillo Sande, MA | 1 |
Ibañes Jalón, E | 1 |
Almaraz Quintana, C | 1 |
Yonekawa, H | 1 |
Shima, S | 1 |
Sugiura, Y | 1 |
Yoshizumi, Y | 1 |
Ohtsuka, H | 1 |
Tanaka, S | 1 |
Ogata, T | 1 |
Escarce, JJ | 1 |
Chiappini, MG | 1 |
Peruzzi, G | 1 |
Vulterini, S | 1 |
Decaux, G | 1 |
Hanson, B | 1 |
Cauchie, P | 1 |
Bosson, D | 1 |
Unger, J | 1 |
Mott, V | 1 |
Bichet, D | 1 |
Rusticali, AG | 1 |
Bölter, C | 1 |
Dorhout Mees, EJ | 1 |
Koomans, HA | 1 |
McCloy, RM | 1 |
Baldus, WP | 2 |
Maher, FT | 1 |
Louis, WJ | 1 |
Doyle, AE | 1 |
Santambrogio, S | 1 |
Natangelo, R | 1 |
Lucchelli, PD | 1 |
Blaise, BH | 1 |
Düsterdieck, G | 3 |
Jahnecke, J | 3 |
Schieffer, H | 1 |
Higazi, AM | 1 |
Khalifa, K | 1 |
el-Ebrashy, N | 1 |
Abdel Hamid, H | 1 |
Safourie, S | 1 |
McGiff, JC | 1 |
Genest, J | 1 |
de Champlain, J | 1 |
Boucher, R | 1 |
Veyrat, R | 2 |
Koiw, E | 1 |
Jayle, MF | 1 |
Legrand, JC | 1 |
Pasqualini, JR | 1 |
Mullane, JF | 1 |
Gliedman, ML | 1 |
Muller, AF | 1 |
Mach, RS | 1 |
Runcan, V | 1 |
Buligescu, L | 2 |
Tutunaru, M | 1 |
Hellman, L | 1 |
Bradlow, HL | 1 |
Zumoff, B | 1 |
Vannotti, A | 1 |
Schmid, E | 1 |
Nomoto, Y | 1 |
Fabre, S | 1 |
Kondo, T | 1 |
Fichman, MP | 1 |
Littenburg, G | 1 |
Brooker, G | 1 |
Mizukoshi, H | 1 |
Miyazaki, T | 1 |
Araki, Y | 1 |
Cottin, S | 1 |
Belet, JL | 1 |
Cadudal, JL | 1 |
Talmant, JC | 1 |
Bailleux, A | 1 |
Ito, T | 1 |
Hidaka, H | 1 |
Kato, T | 1 |
Yoshitoski, Y | 1 |
Arbeiter, G | 1 |
Meyer-Burg, J | 1 |
Carey, RM | 1 |
Wooster, LD | 1 |
Hook, EW | 1 |
Dinicola, AF | 1 |
Conn, HO | 1 |
Solis Herrúzo, JA | 1 |
Stein, JA | 1 |
Curl, FD | 1 |
Valsamis, M | 1 |
Tschudy, DP | 1 |
Williams, JS | 1 |
Reineck, HJ | 1 |
Berezov, VM | 1 |
Liebowitz, HR | 1 |
Inoue, J | 1 |
Mori, Y | 1 |
Kawamura, T | 1 |
Gill, JR | 1 |
Kono, T | 1 |
Holzgreve, H | 1 |
Eigler, J | 1 |
Friedberg, CK | 1 |
Wolfman, EF | 2 |
Kowalczyk, RS | 1 |
Trevino, G | 1 |
Radó, JP | 1 |
Marosi, J | 1 |
Takó, J | 1 |
Dévényi, I | 1 |
Del Greco, F | 1 |
Krumlovsky, F | 1 |
Kawase, M | 1 |
Jick, H | 2 |
Dinç, I | 1 |
Barlas, O | 1 |
Crane, MG | 1 |
Harris, JJ | 1 |
Candiori, R | 1 |
Eggert, RC | 1 |
Barbi, G | 1 |
Giocoli, G | 1 |
Cavina, G | 1 |
Sardini, D | 1 |
Khetagurova, AN | 1 |
Matsuda, T | 1 |
Bull, MB | 1 |
Möhring, J | 1 |
Schaison, G | 1 |
Snyder, JG | 1 |
Moore, EW | 1 |
Miasnikov, AL | 1 |
Gerasimova, EN | 1 |
Zuidema, GD | 1 |
Child, CG | 1 |
Vetter, K | 1 |
Kettler, LH | 1 |
Kaschube, I | 1 |
Lüder, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation[NCT00839358] | Phase 4 | 199 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children: a Pilot Study[NCT04043858] | 20 participants (Anticipated) | Interventional | 2020-06-05 | Recruiting | |||
Albumin Administration in the Prevention of Hepatorenal Syndrome and Death in Patients With Cirrhosis, Bacterial Infections Other Than Spontaneous Bacterial Peritonitis and High Risk of Hospital Mortality[NCT02034279] | Phase 4 | 136 participants (Actual) | Interventional | 2014-05-31 | Terminated (stopped due to Low recruitment rate and expiration of the study drug) | ||
Effects of Intravenous Albumin Administration on Renal Function and Survival in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. A Prospective, Stratified, Randomized and Controlled Study.[NCT00124228] | Phase 3 | 110 participants (Actual) | Interventional | 2004-11-30 | Completed | ||
Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations[NCT02799160] | 22 participants (Actual) | Observational | 2016-10-01 | Active, not recruiting | |||
Efficacy of Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin. A Multi-center Randomized Controlled Study[NCT00986817] | Phase 3 | 82 participants (Actual) | Interventional | 2009-11-30 | Completed | ||
Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis[NCT00108355] | Phase 4 | 29 participants (Actual) | Interventional | 2003-12-31 | Completed | ||
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study[NCT05220891] | 60 participants (Anticipated) | Observational | 2023-01-11 | Not yet recruiting | |||
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure[NCT02429388] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn (stopped due to Principal Investigator left institution prior to subjects being enrolled) | ||
Single-center, Randomized, Double-blind, Placebo-controlled Clinical Trial for the Safety, Tolerability and Efficacy of Ularitide in Cirrhosis Patients With Refractory Ascites.[NCT04311489] | Phase 2 | 17 participants (Actual) | Interventional | 2020-08-01 | Terminated (stopped due to Interim analysis showing safety concerns) | ||
Prospective Study in the Use of the Alfapump® in the Treatment of Malignant Ascites[NCT04076566] | 0 participants (Actual) | Observational | 2020-05-31 | Withdrawn (stopped due to Update to clinical strategy - COVID impact) | |||
Study of Peripheral Microcirculatory Dysfunction in End-stage Liver Disease Patients During Liver Transplantation Using Near Infrared Spectroscopy[NCT01794637] | 0 participants (Actual) | Observational [Patient Registry] | 2013-02-28 | Withdrawn (stopped due to Disposables required for the measurements in short supply and not provided by the company / supplier) | |||
Diagnostic Accuracy of Spleen and Liver Stiffness Measurement by EUS-elastography, to Predict Portal Hypertension in Patients With Cirrhosis.[NCT03155282] | 61 participants (Actual) | Observational | 2017-03-01 | Completed | |||
Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites Management: A Randomized Un-Blinded Pilot Study[NCT02975726] | 2 participants (Actual) | Interventional | 2017-01-31 | Completed | |||
The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients With Ascites and Activation of Sympathetic Nervous System: a Randomized Double-Blind Placebo Controlled Study.[NCT00356226] | 64 participants | Interventional | 2000-10-31 | Completed | |||
Potential Role of Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Ascites in Cirrhotic Patients[NCT05999773] | 40 participants (Anticipated) | Observational | 2023-07-15 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Defined as an increase in Plasma Renin Activity (PRA) by >50% from baseline to a level > 4 ng/mL/h at post-paracentesis day (NCT00108355)
Timeframe: 6 days after paracentesis
Intervention | participants (Number) |
---|---|
Albumin (Control Group) | 2 |
Vasoconstrictor (Treatment Group) | 2 |
Comparison between Albumin (Control group) and Vasoconstrictor (Treatment group) (NCT00108355)
Timeframe: Variable depending on the patient, average 10 days
Intervention | days (Median) |
---|---|
Albumin (Control Group) | 10 |
Vasoconstrictor (Treatment Group) | 8 |
38 reviews available for aldosterone and Liver Cirrhosis
Article | Year |
---|---|
Mineralocorticoid receptors in non-alcoholic fatty liver disease.
Topics: Aldosterone; Fibrosis; Homeostasis; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Rece | 2022 |
ALDOSTERONE AND ANGIOTENSIN. INTERRELATIONSHIPS IN NORMAL AND DISEASED STATES.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensins; Desoxycorticosterone; Digoxin; Dogs; Heart F | 1964 |
ALDOSTERONE IN CLINICAL MEDICINE.
Topics: Aldosterone; Blood Volume; Body Weight; Desoxycorticosterone; Dexamethasone; Diuretics; Drug Therapy | 1964 |
Aldosterone receptor antagonists: biology and novel therapeutical applications.
Topics: Aldosterone; Heart Failure; Hirsutism; Humans; Hyperaldosteronism; Hypertension; Liver Cirrhosis; Mi | 2003 |
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
Topics: Aldosterone; Body Water; Edema; Female; Heart Failure; Humans; Hyponatremia; Liver Cirrhosis; Pregna | 2006 |
[The renin-angiotensin-aldosterone system in liver cirrhosis].
Topics: Aldosterone; Ascites; Humans; Liver; Liver Cirrhosis; Renin-Angiotensin System | 1983 |
[Current theories on the hepatorenal syndrome].
Topics: Aldosterone; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis; Oliguria; Prostaglandi | 1983 |
[Disturbances of water and electrolyte equilibrium in liver disease: Part 2: Clinical picture (author's transl)].
Topics: Aldosterone; Ascites; Hepatitis; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Diseases; Water- | 1982 |
Body fluid homeostasis in congestive heart failure and cirrhosis with ascites.
Topics: Aldosterone; Angiotensin II; Blood Volume; Body Fluids; Body Water; Cardiac Volume; Heart Failure; H | 1982 |
Pathogenesis of ascites and renal salt retention in cirrhosis.
Topics: Aldosterone; Animals; Ascites; Atrial Natriuretic Factor; Blood Volume; Diet, Sodium-Restricted; Diu | 1999 |
Update on peripheral arterial vasodilation, ascites and hepatorenal syndrome in cirrhosis.
Topics: Aldosterone; Animals; Ascites; Hepatorenal Syndrome; Humans; Liver Cirrhosis; Nitric Oxide; Peritoni | 2000 |
Sodium in preascitic cirrhosis: please pass the salt.
Topics: Aldosterone; Atrial Natriuretic Factor; Homeostasis; Humans; Kidney; Liver Cirrhosis; Renin-Angioten | 2001 |
[Liver and steroid hormones. III. Changes in steroid synthesis, concentration and metabolism in liver diseases].
Topics: Aldosterone; Androgens; Chemical Phenomena; Chemistry; Estrogens; Female; Gonadal Steroid Hormones; | 1978 |
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasis.
Topics: Acid-Base Equilibrium; Aldosterone; Angiotensin II; Animals; Blood Volume; Catecholamines; Diuresis; | 1978 |
The kidney in cirrhosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Ascites; Diuretics; Hepatic Encephalopathy; Humans; Hypokalemi | 1976 |
[Changes in renal function and the intracellular environment in cirrhotic patients].
Topics: Aldosterone; Body Fluids; Body Water; Bradykinin; Glomerular Filtration Rate; Humans; Intracellular | 1985 |
Clinical applications of antimineralocorticoids.
Topics: Aldosterone; Angiotensin II; Ascites; Glucose; Heart Failure; Humans; Hypertension; Liver Cirrhosis; | 1988 |
The renin-angiotensin-aldosterone system in human hepatic cirrhosis.
Topics: Aldosterone; Ascites; Extracellular Space; Homeostasis; Humans; Liver Cirrhosis; Renin; Renin-Angiot | 1986 |
[Anomalies of water and sodium excretion by the kidney in decompensated cirrhosis. The theory of blood volume overload opposed to the theory of the diminution of effective circulating volume].
Topics: Aldosterone; Blood Volume; Catecholamines; Diuresis; Humans; Kidney; Liver Cirrhosis; Models, Biolog | 1985 |
[Clinical steroid analysis, using H3 and C14 (determination of their secretion, plasma concentration, secretion rate, as well as metabolism and renal clearance rate)].
Topics: 17-alpha-Hydroxypregnenolone; Adrenal Cortex Hormones; Aldosterone; Carbon Isotopes; Chemistry, Clin | 1965 |
Aldosterone in clinical medicine.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Heart Failure; Humans; Hyperaldosteronism; | 1968 |
Tissue hormones: angiotensin, bradykinin and the regulation of regional blood flows.
Topics: Aldosterone; Angiotensin II; Animals; Autonomic Nervous System; Bradykinin; Calcium; Catecholamines; | 1968 |
[Recent data on the physiopathologic metabolism of aldosterone].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Aorta; Edema; Female; Heart Disea | 1967 |
Recent advances in human steroid metabolism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Carbon Isotopes; Dexamethasone; Estriol; Etiocholanolone; | 1970 |
[Peptide metabolism in liver insufficiency].
Topics: Aldosterone; Angiotensin II; Animals; Aprotinin; Gastric Juice; Gastrins; Hepatitis; Histamine; Huma | 1969 |
[Liver cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Juxtaglomerular Apparatus; Kidney; Liver; Liver Cirrho | 1971 |
[Abnormalities of sodium and water metabolism with special reference to hypertensive diseases].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hype | 1972 |
Renal failure in advanced liver disease.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Body Water; Hemodynamics; Humans; Kidney; | 1972 |
The rational management of ascites.
Topics: Albumins; Aldosterone; Animals; Ascites; Ascitic Fluid; Diet, Sodium-Restricted; Diuretics; Dogs; Dr | 1972 |
[Renal functioning and hydroelectric equilibrium in the cirrhotic patient].
Topics: Aldosterone; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kidney Glomerulus; Liver; Liv | 1974 |
[Pathogenesis and treatment of the edema-ascites syndrome in patients with cirrhosis of the liver].
Topics: Adrenal Cortex Hormones; Aldosterone; Ascites; Diet Therapy; Edema; Humans; Liver Cirrhosis; Lymphat | 1967 |
Pathogenesis of ascites in cirrhosis of liver. II.
Topics: Aldosterone; Animals; Ascites; Ascitic Fluid; Ethanol; Heart Failure; Hemodynamics; Humans; Hyperald | 1969 |
[Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Topics: Aldosterone; Ascites; Blood Proteins; Capillary Permeability; Diuretics; Edema; Electrolytes; Humans | 1969 |
Edema.
Topics: Aldosterone; Animals; Disease Models, Animal; Dogs; Edema; Heart Failure; Humans; Hyponatremia; Kidn | 1970 |
[Recent knowledge of diseases with abnormal aldosterone secretion].
Topics: Addison Disease; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aldosterone; A | 1971 |
[Renal regulation of the sodium balance].
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Capillaries; Dogs; Glomerular Filtration Rate; He | 1971 |
Edema and pulmonary edema: pathologic physiology and differential diagnosis.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Edema; Extracellular Space; Female; Heart Dise | 1971 |
Salt, water and adrenal steroid metabolism.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Ascites; Corticosterone; Diet, Sodium-Restricted; Dog | 1964 |
38 trials available for aldosterone and Liver Cirrhosis
Article | Year |
---|---|
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Topics: Adult; Aged; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Follow-Up Studies; Humans; | 2018 |
Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Topics: Albumins; Aldosterone; Ascites; Creatinine; Female; Humans; Hypovolemia; Liver Cirrhosis; Male; Midd | 2014 |
VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis.
Topics: Aldosterone; Chemokines; DNA Primers; Feces; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Pol | 2013 |
Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.
Topics: Aldosterone; Anti-Infective Agents; Ascites; Blood Pressure; Body Weight; Diuretics; Drug Therapy, C | 2016 |
Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
Topics: Aldosterone; Bacterial Translocation; Endotoxins; Female; Humans; Hypertension, Portal; Interleukin- | 2009 |
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
Topics: Adult; Aged; Albumins; Aldosterone; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bacterial Infe | 2012 |
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
Topics: Adult; Aged; Albumins; Aldosterone; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bacterial Infe | 2012 |
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
Topics: Adult; Aged; Albumins; Aldosterone; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bacterial Infe | 2012 |
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
Topics: Adult; Aged; Albumins; Aldosterone; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bacterial Infe | 2012 |
A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Topics: Aldosterone; Antidiuretic Hormone Receptor Antagonists; Ascites; Azepines; Benzamides; Edema; Female | 2003 |
[Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Kidney; Kidney Function | 2004 |
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Blood Volume; Creatinine; Drug Therapy, C | 2004 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Topics: Albumins; Aldosterone; Ascites; Blood Volume; Female; Hemodynamics; Humans; Liver Cirrhosis; Lypress | 2006 |
The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Furosemide; Gastroi | 2006 |
Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
Topics: Adult; Albumins; Aldosterone; Blood Volume; Drug Costs; Female; Humans; Liver Cirrhosis; Male; Middl | 2006 |
The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarke | 2006 |
Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Cross-Over Studies; Diuretics; Female; Human | 2007 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Topics: Adrenergic alpha-Agonists; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Humans; Hypo | 2008 |
Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Topics: Aldosterone; Hepatic Veins; Humans; Kidney; Liver Cirrhosis; Propranolol; Renal Circulation; Renin; | 1984 |
Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Dextrans; Diuretics; Female; Follow-Up Studies | 1994 |
Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Blood Pressure; Female; Furosemide; Glomerular Filtration | 1995 |
Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Topics: Aldosterone; Analysis of Variance; Body Water; Chi-Square Distribution; Dinoprostone; Drug Therapy, | 1994 |
Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial.
Topics: Adult; Aged; Albumins; Aldosterone; Ascites; Blood Pressure; Cardiac Output; Female; Humans; Infusio | 1993 |
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Amiloride; Ascites; Canrenoic Acid; Female; Humans; Kid | 1994 |
Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion.
Topics: Aldosterone; Atrial Natriuretic Factor; Drug Resistance; Female; Humans; Immersion; Infusions, Intra | 1993 |
Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Ascites; Blood Pressure; Blood Urea Nitrogen; | 1996 |
Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
Topics: Aldosterone; Ascites; Combined Modality Therapy; Diuretics; Dose-Response Relationship, Drug; Double | 1997 |
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
Topics: Aldosterone; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Femal | 1997 |
Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism.
Topics: Aldosterone; Cisapride; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Piperidines; Sero | 1998 |
Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Ascites; Blood Pressure; Blood Volume; Cardiac Outpu | 1998 |
Sodium retention in preascitic stage of cirrhosis.
Topics: Aldosterone; Analysis of Variance; Female; Glomerular Filtration Rate; Humans; Inulin; Kidney; Liver | 2001 |
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
Topics: Aged; Aldosterone; Blood Pressure; Cross-Over Studies; Enzyme Inhibitors; Female; Glomerular Filtrat | 2001 |
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.
Topics: Aldosterone; Antihypertensive Agents; Ascites; Blood Volume; Homeostasis; Humans; Liver Cirrhosis; L | 2002 |
Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis.
Topics: Adult; Aldosterone; Captopril; Catecholamines; Drug Administration Schedule; Hemodynamics; Hormones; | 1992 |
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Dextrans; Female; Follow-Up Studies; Hospitali | 1990 |
Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Humans; Inhalation; Liver Cirrhosis; | 1991 |
Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites.
Topics: Administration, Oral; Adult; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relat | 1991 |
The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Biological Availa | 1989 |
Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Topics: Aldosterone; Canrenoic Acid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperald | 1988 |
Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.
Topics: Adult; Aged; Aldosterone; Bumetanide; Diuretics; Female; Glomerular Filtration Rate; Heart Failure; | 1986 |
[Drug therapy of chronic inflammatory liver diseases].
Topics: Aldosterone; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Nandrolone; Predni | 1966 |
319 other studies available for aldosterone and Liver Cirrhosis
Article | Year |
---|---|
Can we predict early renal impairment in pediatric cirrhosis?
Topics: Acute Kidney Injury; Albumins; Aldosterone; Ascites; Child; End Stage Liver Disease; Female; Humans; | 2022 |
Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study.
Topics: Aldosterone; Amidohydrolases; Apelin; Astragalus Plant; Chromatography, High Pressure Liquid; Diures | 2022 |
Effects of adding hypertonic saline solutions and/or etilefrine to standard diuretics therapy in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Biomarkers; C-Reactive Protein; Creatinine; Diuretics; Etilefrine; Furosemide; | 2022 |
Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression.
Topics: Aldosterone; Animals; Colon; Epithelial Sodium Channels; Gene Expression; Hypovolemia; Kidney; Liver | 2023 |
Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
Topics: Aldosterone; Animals; Cells, Cultured; Gene Expression; Gene Expression Regulation, Developmental; H | 2020 |
Internal dysregulation of the renin system in patients with stable liver cirrhosis.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Creatinine; Female; Glomer | 2017 |
Caveolin 1-related autophagy initiated by aldosterone-induced oxidation promotes liver sinusoidal endothelial cells defenestration.
Topics: Actins; Aldosterone; AMP-Activated Protein Kinase Kinases; Animals; Autophagy; Capillaries; Caveolin | 2017 |
Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes.
Topics: Aldosterone; Animals; Blood Pressure; Blotting, Western; Cyclic N-Oxides; Histocytochemistry; Liver | 2014 |
Aldosterone and TGF-β₁ synergistically increase PAI-1 expression in hepatic stellate cells of rats.
Topics: Aldosterone; Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Hepatic Stellate C | 2015 |
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Di | 2016 |
Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
Topics: Adult; Aged; Aldosterone; Biomarkers; Biomechanical Phenomena; Blood Pressure; Case-Control Studies; | 2016 |
Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
Topics: Aged; Aldosterone; Angiotensinogen; Angiotensins; Ascites; Ascitic Fluid; Female; Humans; Liver Cirr | 2008 |
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Topics: Adult; Aged; Aldosterone; Female; Glomerular Filtration Rate; Hemodynamics; Hepatorenal Syndrome; Hu | 2010 |
Solute-free water retention in preascitic cirrhotic rats following intravenous water loading.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Extracellular Fluid; Glomerular Filtration Rate; Ki | 2009 |
Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats.
Topics: Aldosterone; Animals; Disease Progression; Fatty Liver; Liver Cirrhosis; Liver Neoplasms; Male; Rats | 2010 |
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis.
Topics: Adult; Aged; Aldosterone; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hyperten | 2011 |
Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Topics: Acute-Phase Proteins; Adult; Aged; Aldosterone; Analysis of Variance; Bacterial Translocation; Carri | 2011 |
Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Biomarkers; Diuretics; Drug Therapy, Combinati | 2011 |
Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.
Topics: Actins; Aldosterone; Animals; Cyclic GMP-Dependent Protein Kinases; Immunohistochemistry; Liver; Liv | 2012 |
Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback.
Topics: Adult; Aldosterone; Case-Control Studies; Creatinine; Female; Humans; Kidney; Kidney Glomerulus; Kid | 2002 |
Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
Topics: Aldosterone; Amino Acids; Ascites; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Hu | 2002 |
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracell | 2003 |
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atri | 2003 |
Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease.
Topics: Adult; Aged; Aldosterone; Arteries; Blood Pressure; Compliance; Female; Humans; Liver Circulation; L | 2003 |
Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis.
Topics: Adult; Aldosterone; Blood Pressure; Case-Control Studies; Diastole; Echocardiography; Female; Fibros | 2003 |
[Urinary aldosterone excretion in epidemic hepatitis and in liver cirrhosis].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Hepatitis; Hepatitis A; Humans; Liver Cirrhosi | 1955 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
Effect of amphenone therapy of urinary excretion of aldosterone and sodium in hepatic cirrhosis with ascites.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Propiophenones; Sodium; Sodium, Dietary | 1957 |
Aldosterone excretion in patients with cirrhosis of the liver.
Topics: Aldosterone; Biological Transport; Humans; Liver Cirrhosis | 1957 |
Chloride, potassium, and aldosterone excretion in a sodium-retaining patient (hepatic cirrhosis) during forced natriuresis.
Topics: Aldosterone; Body Fluids; Chlorides; Humans; Hypernatremia; Liver Cirrhosis; Natriuresis; Potassium; | 1958 |
The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolacton | 1958 |
[Aldosterone in liver cirrhosis].
Topics: Aldosterone; Ascites; Digestion; Humans; Liver Cirrhosis | 1958 |
[Notes on supposed relations between some steroids and aldosterone in edematigenous syndromes].
Topics: Adrenal Cortex Hormones; Aldosterone; Heart Failure; Humans; Kidney Neoplasms; Liver Cirrhosis; Neop | 1958 |
The effect of prednisone and amphenone on fluid and electrolyte balance and on aldosterone excretion of patients with cirrhosis and ascites.
Topics: Aldosterone; Ascites; Body Fluids; Humans; Liver Cirrhosis; Prednisone; Propiophenones; Water-Electr | 1959 |
[Treatment of edema in liver cirrhosis with a spirolactone, aldactone].
Topics: Aldosterone; Diuretics; Edema; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Chem | 1961 |
[Study of the action of spirolactone in edematous alcoholic cirrhosis].
Topics: Aldosterone; Diuretics; Edema; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Mineralocorticoid Recept | 1961 |
[First trials of treatment of the edematous syndrome in liver cirrhoses with spirolactones. (Apropos of 11 cases)].
Topics: Aldosterone; Diuretics; Edema; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolacto | 1961 |
Antagonism of aldosterone by progesterone. Effect of progesterone in two cases of hepatic cirrhosis.
Topics: Aldosterone; Hostility; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Che | 1960 |
Sodium and water diuresis in cirrhotic patients with intractable ascites following chemical inhibition of aldosterone synthesis.
Topics: Aldosterone; Ascites; Diuresis; Humans; Liver Cirrhosis; Pyridines; Sodium; Sodium, Dietary | 1960 |
[First results in the use of aldactone in 15 cases of ascitic cirrhosis].
Topics: Aldosterone; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Chemicals; | 1961 |
A comparison of the properties of chlorothiazide, spironolactone and a combination of both as diuretic agents.
Topics: Aldosterone; Chlorothiazide; Diuretics; Heart Failure; Liver Cirrhosis; Mineralocorticoid Receptor A | 1961 |
[Cortisone-like drugs in the therapy of water and salt retention in cirrhotic and cardiac patients in the decompensation phase. Relation to the urinary elimination of aldosterone. antidiuretic substances and electrolytes].
Topics: Adrenal Cortex Hormones; Aldosterone; Cortisone; Electrolytes; Heart Failure; Humans; Liver Cirrhosi | 1960 |
[Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
Topics: Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Ch | 1961 |
Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolacton | 1961 |
[Changes in urinary aldosterone and the role of hyperaldosteronism in the hydropigenous syndrome of cirrhotics].
Topics: Aldosterone; Humans; Hyperaldosteronism; Liver Cirrhosis; Syndrome | 1961 |
Combined diuretic and steroid therapy in cirrhosis with ascites.
Topics: Adrenal Cortex Hormones; Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Recepto | 1960 |
Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention.
Topics: Aldosterone; Diuretics; Heart Failure; Humans; Liver Cirrhosis; Sodium | 1961 |
[Spirolactones in the treatment of ascitic cirrhoses (26 cases)].
Topics: Aldosterone; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Chemicals; | 1961 |
[Spirolactone. Its use in the treatment of cardiac and cirrhotic edema. Apropos of 6 case reports].
Topics: Aldosterone; Diuretics; Edema; Heart Failure; Liver Cirrhosis; Spironolactone | 1961 |
[Spirolactones. Their use in the treatment of cardiac and cirrhotic edemas (apropos of 6 case reports)].
Topics: Aldosterone; Diuretics; Edema; Heart Failure; Liver Cirrhosis; Mineralocorticoid Receptor Antagonist | 1960 |
[Spirolactone, an aldosterone-antagonistic steroid. Illustration of its effects on a patient with liver cirrhosis].
Topics: Aldosterone; Antihypertensive Agents; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagon | 1960 |
[Aldosterone excretion, electrolyte--and water balance under the influence of prednisone in healthy volunteers and in patients with liver cirrhosis].
Topics: Aldosterone; Electrolytes; Healthy Volunteers; Humans; Liver Cirrhosis; Prednisone; Water-Electrolyt | 1959 |
[Effect of SC 9420, mercurial diuretic and hydrochlorothiazide on electrolyte excretion in liver cirrhosis].
Topics: Aldosterone; Chlorothiazide; Diuretics; Electrolytes; Humans; Hydrochlorothiazide; Liver Cirrhosis; | 1959 |
[Cirrhotic edemas and spironolactone].
Topics: Aldosterone; Diuretics; Edema; Edetic Acid; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; | 1962 |
[Metopirone used in combination therapy of resistant cirrhotic edemas].
Topics: Aldosterone; Combined Modality Therapy; Edema; Edetic Acid; Liver Cirrhosis; Metyrapone; Mineralocor | 1962 |
[Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1962 |
Observations on the mechanism and treatment of ascites in hepatic cirrhosis.
Topics: Aldosterone; Ascites; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists | 1962 |
The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis.
Topics: Aldosterone; Humans; Lipid Metabolism; Liver Cirrhosis | 1962 |
[Spirolactone (Aldactone) in ascites caused by liver cirrhosis].
Topics: Aldosterone; Ascites; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Spironolactone | 1962 |
Long-term medical management and complications of 'resistant' ascites.
Topics: Aldosterone; Ascites; Diuretics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists | 1961 |
[Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1961 |
[Determination of loosely bound aldosterone in the blood of healthy and sick people].
Topics: Aldosterone; Humans; Hypertension; Hypertension, Renal; Kidney; Liver Cirrhosis; Nephrotic Syndrome | 1963 |
[Triamterene, a supposed aldosterone inhibitor. Diuretic activity in edematous subjects].
Topics: Aldosterone; Diuretics; Edema; Heart Failure; Liver Cirrhosis; Mineralocorticoid Receptor Antagonist | 1963 |
[Studies on the urinary excretion of aldosterone. II. On the role of aldosterone in the pathogenesis of some clinical syndromes].
Topics: Aldosterone; Diabetes Insipidus; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Liv | 1962 |
[Preliminary observation on the clinical use of aldosterone antagonistic drugs (spironolactone) in edemigenic syndromes].
Topics: Aldosterone; Diuretics; Edema; Heart Failure; Humans; Liver Cirrhosis; Mineralocorticoid Receptor An | 1962 |
[Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
Topics: Aldosterone; Ascites; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Sp | 1961 |
OBSERVATIONS ON METABOLISM OF ALDOSTERONE IN MAN.
Topics: Aldosterone; Blood Circulation; Heart Failure; Humans; Liver Cirrhosis; Male; Metabolism; Tritium | 1963 |
[A FUNCTION TEST FOR INDIRECT APPRAISAL OF MINERALOCORTICOID RESERVE OF HUMAN ADRENAL CORTEX].
Topics: Addison Disease; Adrenal Cortex; Adrenal Insufficiency; Aldosterone; Angiotensins; Heart Failure; Hu | 1963 |
[ON THE MECHANISM OF ACTION OF THE DIURETIC ACTIVITY OF 2,4,7-TRIAMINO-6-PHENYL-PTERIDINE (TRIAMTERENE)].
Topics: Aldosterone; Ascites; Blood Chemical Analysis; Body Weight; Diuretics; Heart Failure; Humans; Hypera | 1963 |
[OUR EXPERIENCE IN THE TREATMENT OF PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS WITH ALDOSTERONE INHIBITORS].
Topics: Aldosterone; Humans; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Prednisone | 1963 |
VARIATIONS IN PLASMA RENIN CONCENTRATION IN SEVERAL PHYSIOLOGICAL AND PATHOLOGICAL STATES.
Topics: Addison Disease; Aldosterone; Angiotensins; Blood Chemical Analysis; Hypertension; Hypokalemia; Live | 1964 |
[DIURESIS, ELECTROLYTES AND ALDOSTERONE AFTER TRIAMTERENE: FINDINGS IN THE SO-CALLED "REFRACTORY EDEMAS" OF PATIENTS WITH HEART DISEASE AND LIVER CIRRHOSIS].
Topics: Aldosterone; Ascites; Diuresis; Diuretics; Edema; Electrolytes; Heart Failure; Liver Cirrhosis; Pter | 1963 |
[USE OF AN INHIBITOR OF ALDOSTERONE SYNTHESIS (SU-4885, METOPIRONE) IN SOME REFRACTORY EDEMATOUS STATES].
Topics: Aldosterone; Ascites; Edema; Heart Failure; Hepatitis; Ketones; Liver Cirrhosis; Metyrapone; Mineral | 1963 |
THE JUXTAGLOMERULAR APPARATUS AND ALDOSTERONE IN HYPERALDOSTERONISM.
Topics: Aldosterone; Angiotensins; Biomedical Research; Carcinoma, Hepatocellular; Cushing Syndrome; Hepatit | 1964 |
[PLACE OF ALDACTONE IN THE THERAPY OF EDEMA].
Topics: Aldosterone; Edema; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Spironolactone | 1964 |
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extra | 1964 |
[ALTERATIONS IN THE EXCRETION OF ALDOSTERONE AND ELECTROLYTES IN HEPATIC CIRRHOSIS, CONGESTIVE HEART FAILURE AND IDIOPATHIC EDEMAS].
Topics: 17-Ketosteroids; Aldosterone; Ascites; Edema; Electrolytes; Heart Failure; Humans; Liver Cirrhosis; | 1964 |
EXPERIMENTAL ASCITES. VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood; Blood Pressure; Budd-Chiari Syndrome; Dogs; Hepatic Vei | 1964 |
THE ROLE OF ADRENALECTOMY IN THE MANAGEMENT OF INTRACTABLE ASCITES.
Topics: Adrenalectomy; Aldosterone; Ascites; Cortisone; Diet; Diet Therapy; Humans; Hydrocortisone; Liver Ci | 1964 |
[ON CHANGES IN BLOOD VESSEL WALL ELECTROLYTES AND THE ADRENAL CORTEX IN EXPERIMENTAL HYPERTENSION].
Topics: Adrenal Cortex; Aldosterone; Aorta; Blood Pressure Determination; Carbon Tetrachloride Poisoning; Co | 1964 |
[ALDOSTERONE INHIBITORS IN THE TREATMENT OF EDEMAS].
Topics: Aldosterone; Ascites; Drug Therapy; Edema; Geriatrics; Heart Failure; Humans; Liver Cirrhosis; Miner | 1964 |
ROLE OF LIVER DAMAGE IN INCREASING ALDOSTERONE EXCRETION IN PATIENTS OF CIRRHOSIS AND ASCITES.
Topics: Aldosterone; Ascites; Body Fluids; Humans; Liver; Liver Cirrhosis; Liver Diseases; Punctures; Urine | 1964 |
[CLINICAL APPLICATION OF RADIOACTIVE STEROIDS].
Topics: Addison Disease; Adrenal Insufficiency; Aldosterone; Blood Proteins; Carbon Isotopes; Chemical Pheno | 1964 |
[EFFECT OF BLOCKADE OF THE PERIPHERAL ACTION OF ALDOSTERONE ON THE EFFECT OF ANGIOTENSIN IN LIVER CIRRHOSIS].
Topics: Aldosterone; Angiotensins; Ascites; Diuresis; Drug Therapy; Humans; Liver Cirrhosis | 1964 |
URINARY ALDOSTERONE EXCRETION IN CIRRHOSIS OF LIVER WITH ASCITES AND ITS RELATIONSHIP WITH PLASMA VOLUME AND ELECTROLYTES.
Topics: Aldosterone; Ascites; Electrolytes; Humans; Liver Cirrhosis; Plasma Volume; Urine | 1965 |
[INVESTIGATION OF PLASMA ALDOSTERONE AND ALDOSTERONE METABOLISM IN HEALTHY SUBJECTS AND PATIENTS WITH HEART, LIVER AND KIDNEY DISEASE].
Topics: Aldosterone; Blood; Healthy Volunteers; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hyp | 1965 |
RELATIONSHIP OF URINARY ALDOSTERONE AND 17-HYDROXY-CORTICOSTEROID EXCRETION IN THE CIRRHOSIS OF LIVER.
Topics: 17-Hydroxycorticosteroids; Aldosterone; Body Fluids; Humans; Liver Cirrhosis | 1965 |
PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.
Topics: Aldosterone; Angiotensin II; Angiotensins; Ascites; Blood Pressure; Body Fluids; Dexamethasone; Huma | 1965 |
[The aldosterone-antagonistic effect of progesterone. A preliminary note on the effects of progesterone on 2 patients with liver cirrhosis].
Topics: Aldosterone; Antihypertensive Agents; Diuretics; Humans; Liver Cirrhosis; Mineralocorticoid Receptor | 1960 |
The use of an aldosterone antagonist in patients with cirrhosis.
Topics: Aldosterone; Antihypertensive Agents; Diuretics; Hormone Antagonists; Liver Cirrhosis; Mineralocorti | 1960 |
[Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas].
Topics: Aldosterone; Diuretics; Edema, Cardiac; Edetic Acid; Heart Failure; Liver Cirrhosis; Mineralocortico | 1961 |
[The place of spirolactones in the treatment of ascitogenic cirrhosis].
Topics: Aldosterone; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Organic Chemicals; Spironolact | 1962 |
[Spirolactone treatment of liver cirrhosis with edema and ascites].
Topics: Aldosterone; Ascites; Edema; Edetic Acid; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; O | 1962 |
[Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
Topics: Aldosterone; Diuretics; Edema; Heart Failure; Humans; Liver Cirrhosis; Mineralocorticoid Receptor An | 1962 |
The influence of continuous seven-day elevated intra-abdominal pressure in the renal perfusion in cirrhotic rats.
Topics: Abdomen; Aldosterone; Animals; Blood Pressure; Carbon Tetrachloride; Catheterization; Femoral Artery | 2003 |
Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats.
Topics: Aldosterone; Animals; Blotting, Western; Common Bile Duct; Enzyme Inhibitors; Female; Glomerular Fil | 2004 |
[Effects of aldosterone and spironolactone on the proliferation and collagen synthesis of hepatic stellate cells in rats].
Topics: Aldosterone; Animals; Cell Division; Collagen; Liver; Liver Cirrhosis; Rats; Spironolactone | 2003 |
Corticosteroids stimulate selectively transforming growth factor (TGF)-beta receptor type III expression in transdifferentiating hepatic stellate cells.
Topics: Activin Receptors, Type I; Adrenal Cortex Hormones; Aldosterone; Animals; Cell Differentiation; Cell | 2004 |
[Effect of aldosterone on the collagen synthesis and TIMP-1 mRNA level in cultured rat hepatic stellate cells].
Topics: Aldosterone; Animals; Cells, Cultured; Collagen Type I; Collagen Type III; Dose-Response Relationshi | 2004 |
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
Topics: Abdomen; Aldosterone; Ascites; Ascitic Fluid; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Ni | 2004 |
Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Dopamine Antagonists; Female; Humans; Kidney; Kidney Tubules, Distal; Lith | 2005 |
[Effects of angiotensin II and aldosterone on NF-kappaB binding activity in hepatic stellate cells].
Topics: Aldosterone; Angiotensin II; Animals; DNA-Binding Proteins; I-kappa B Proteins; Liver; Liver Cirrhos | 2005 |
Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.
Topics: Absorption; Adrenergic alpha-Agonists; Aldosterone; Calcium; Female; Humans; Infusions, Intravenous; | 2007 |
Large volume abdominal paracentesis effect on some humoral factors and cardiac performance in patients with liver cirrhosis and tense ascities.
Topics: Adult; Aged; Aldosterone; Ascitic Fluid; Blood Circulation; Epinephrine; Female; Humans; Liver Cirrh | 2007 |
[Secondary aldosteronism in patients with liver cirrhosis and excretion of aldosterone in them following vascular anastomosis].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension, Portal; Liver Cirr | 1966 |
Exchange of aldosterone between plasma and thoracic duct lymph.
Topics: Aldosterone; Animals; Arthritis, Rheumatoid; Ascites; Carbon Isotopes; Dogs; Edema; Esophageal and G | 1967 |
[Plasma aldosterone in compensated liver cirrhosis].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Circadian Rhythm; Female; Hum | 1984 |
Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
Topics: Aldosterone; Arginine Vasopressin; Ascites; Body Water; Creatinine; Diuresis; Humans; Hyponatremia; | 1983 |
The kinin system and other vasoactive substances in chronic liver disease.
Topics: Aldosterone; Chronic Disease; Diuresis; Humans; Kallikreins; Kinins; Liver Cirrhosis; Liver Diseases | 1983 |
Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.
Topics: Adult; Aged; Aldosterone; Ascites; Blood Volume; Female; Humans; Kidney Function Tests; Liver Cirrho | 1983 |
[Relation existing between the kallikrein-kinin and renin-angiotensin-aldosterone systems].
Topics: Aldosterone; Humans; Hypertension; Kallikreins; Kinins; Liver Cirrhosis; Renin; Renin-Angiotensin Sy | 1983 |
Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
Topics: Adult; Aged; Aldosterone; Alprostadil; Angiotensin II; Body Water; Female; Humans; Infusions, Parent | 1984 |
Diuretic treatment and renin-aldosterone axis in liver cirrhosis.
Topics: Aldosterone; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Natriuresis; Renin-Angiotensin Sys | 1984 |
[Blood content of testosterone, progesterone and aldosterone in patients with chronic hepatitis and liver cirrhosis].
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Cir | 1984 |
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion.
Topics: Adult; Aldosterone; Blood Volume; Creatinine; Female; Humans; Kallikreins; Liver Cirrhosis; Male; Mi | 1984 |
Sodium and fluid retention in hepatic cirrhosis: a role for circulating hormones?
Topics: Aldosterone; Ascites; Body Fluids; Diuretics; Hormones; Humans; Liver Cirrhosis; Natriuresis; Plasma | 1984 |
[Possible correlation between intralymphocytic sodium and plasma aldosterone].
Topics: Aldosterone; Humans; Hypertension; Liver Cirrhosis; Lymphocytes; Sodium | 1983 |
Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Body Water; Female; Humans; Kidney; Liver C | 1982 |
[Estimation of plasma renin, angiotensin II and urinary aldosterone in patients with cirrhosis of liver and its clinical significance].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Age | 1982 |
Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Hemodynamics; Humans; Liver Circulation | 1981 |
Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease.
Topics: Adult; Aldosterone; Analysis of Variance; Angiotensin II; Chronic Disease; Female; Humans; Liver Cir | 1981 |
Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Child; Diet, Sodium-Restricted; Fe | 1980 |
Renin-angiotensin-aldosterone in cirrhotic ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Humans; Liver Cirrhosis; Renin | 1980 |
Renin-angiotensin-aldosterone system in cirrhosis.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Ascites; Blood Volume; Edema; Extracellular Space; | 1980 |
Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.
Topics: Adult; Aldosterone; Ascites; Female; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Midd | 1981 |
Cirrhosis, renin, and aldosterone.
Topics: Aldosterone; Animals; Dogs; Humans; Liver Cirrhosis; Rats; Renin | 1981 |
Factors relating to aldosterone secretion rate, the excretions of aldosterone 18-glucuronide, and the plasma aldosterone concentration in cirrhosis.
Topics: Adult; Aged; Aldosterone; Female; Glucuronates; Humans; Liver Cirrhosis; Male; Middle Aged; Renin; S | 1981 |
[Physiopathology and therapy of the ascites in liver cirrhosis].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Sod | 1982 |
[What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Diuretics; Humans; Hyperaldosteronism; Liver Cirrhosi | 1981 |
Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Drug Therapy, Combination; Female; Humans; Liver Cirrh | 1980 |
[Effects of changes in central hemodynamics and hormonal systems of its regulation on the etiology of portal hypertension complications in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Echocardiography; Female; Heart; Hemodynamics; Humans | 1995 |
Effect of the serine protease inhibitor, aprotinin, on systemic haemodynamics and renal function in patients with hepatic cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Aprotinin; Ascites; Blood Pressure; Female; Glomerular Fil | 1994 |
Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
Topics: Aldosterone; Female; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Norepine | 1995 |
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; | 1995 |
High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Female; Hematocrit; Humans; Liver Cirrhosis; Ma | 1995 |
Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels.
Topics: Aldosterone; Atrial Natriuretic Factor; Exercise; Female; Humans; Liver Cirrhosis; Male; Middle Aged | 1995 |
Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Humans; Kidney; Liver Cirrhosis; Male; | 1994 |
[ANP in the cirrhotic patient. A clinical contribution].
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver Cirrhosis; Male; Middl | 1994 |
The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children.
Topics: Adolescent; Aldosterone; Child; Female; Glucose; Hepatitis B; Humans; Infusions, Intravenous; Liver | 1994 |
[The effect of water immersion on humoral and urinary parameters in healthy persons and in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Proteins; Cardenolides; D | 1994 |
Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis.
Topics: Adult; Aldosterone; Ascites; Blood Coagulation; Blood Component Removal; Female; Humans; Kidney; Liv | 1994 |
Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.
Topics: Abdomen; Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Circulation; Echocardio | 1994 |
[Renal resistance to atrial natriuretic factor as a cause of the escape failure phenomenon in patients with non-ascitic liver cirrhosis].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Female; Fludrocortisone; Humans; Kidney; | 1994 |
Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
Topics: Aldosterone; Captopril; Furosemide; Humans; Hyperkalemia; Hypertension; Hypoaldosteronism; Liver Cir | 1993 |
Taurine-induced diuresis and natriuresis in cirrhotic patients with ascites.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Blood Pressure; | 1994 |
Pathophysiological characteristics of cutaneous microcirculation in patients with liver cirrhosis: relationships to cardiovascular hemodynamics and plasma neurohormonal factors.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Cardiovascular System; Female; Hemodynamics; Hormones; Hum | 1993 |
Central blood volume in cirrhosis: measurement with radionuclide angiography.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Blood Volume D | 1994 |
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Female; Hemato | 1993 |
Atrial natriuretic peptide and hemodynamic changes after concentrated ascitic fluid reinfusion in cirrhotic patients.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Cardiac Output; Diuresis | 1993 |
Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.
Topics: Aldosterone; Arteriovenous Fistula; Blood Pressure; Blood Volume; Cardiac Output; Female; Hemodynami | 1993 |
Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Hemodynamics; Humans; Hypertension, Portal; Isosorb | 1993 |
Plasma volume contraction in portal hypertension.
Topics: Aged; Aldosterone; Blood Pressure; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynamic | 1993 |
Renal sodium retention during upright posture in preascitic cirrhosis.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Humans; Kidney; Liver Cirrhosis; Male; Middle A | 1993 |
Perioperative plasma concentrations of endothelin and natriuretic peptides in children undergoing living-related liver transplantation.
Topics: Aldosterone; Atrial Natriuretic Factor; Biliary Atresia; Blood Pressure; Child; Child, Preschool; En | 1996 |
[Neurohumoral activity in liver cirrhosis].
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Proteins; Cardenolides; Digoxin; Diuresis | 1995 |
Systemic hemodynamics and serum nitrate levels in patients undergoing endoscopic variceal ligation.
Topics: Aldosterone; Analysis of Variance; Bile Acids and Salts; Blood Pressure; Cardiac Output; Echocardiog | 1996 |
Relation of endothelins to volume regulating neurohumoral systems in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diuretic | 1995 |
Urinary excretion of urodilatin in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Ascites; Atrial Natriuretic Factor; Biomarkers; Creatinine; Femal | 1996 |
Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.
Topics: Aged; Aldosterone; Ascites; Creatinine; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypertens | 1997 |
Circadian rhythms of plasma atriopeptin, plasma renin activity and plasma aldosterone in patients with hepatorenal syndrome.
Topics: Aldosterone; Atrial Natriuretic Factor; Circadian Rhythm; Female; Hepatorenal Syndrome; Humans; Line | 1997 |
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Topics: Aged; Albumins; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Cardiac Output; Diure | 1997 |
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Hemodynamics; Humans; Kidney; | 1997 |
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Hemodynamics; Humans; Kidney; | 1997 |
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Hemodynamics; Humans; Kidney; | 1997 |
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Hemodynamics; Humans; Kidney; | 1997 |
Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.
Topics: Aldosterone; Anemia; Blood Pressure; Blood Volume; Cardiac Output; Cohort Studies; Female; Hemodynam | 1997 |
Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Ki | 1997 |
Plasma adrenomedullin levels in patients with hepatic cirrhosis.
Topics: Adrenomedullin; Adult; Aged; Aldosterone; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Age | 1997 |
Urinary endothelin-like immunoreactivity in patients with cirrhosis.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Endothelins; Female; Hepatorenal Syndrome; H | 1997 |
Endogenous dopaminergic activity in Child-Pugh A cirrhosis: potential role in renal sodium handling and in the maintenance of clinical compensation.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Dopamine; Female; Humans; Kidney; Liver Cirrh | 1998 |
Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Blood Pressure; Epoprostenol; Female; Glucagon; Heart Rate; Hemodynamics; Huma | 1998 |
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis.
Topics: Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; C | 1998 |
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Topics: Aged; Aldosterone; Ascites; Blood Pressure; Endotoxins; Female; Hepatic Encephalopathy; Humans; Inte | 1999 |
Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Creatinine; Female; Follow-Up Studies; Humans; | 1999 |
Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis.
Topics: Adult; Aldosterone; Female; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Norepi | 1999 |
Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Topics: Adult; Aged; Aldosterone; Female; Hemodynamics; Humans; Hyponatremia; Kidney Function Tests; Liver C | 1999 |
Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.
Topics: Adult; Aged; Aldosterone; Case-Control Studies; Creatinine; Dopamine Antagonists; Female; Humans; Ki | 1999 |
High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Female; Humans; Liver Cirrhosis; Ma | 2000 |
Changes in circulating levels of atrial natriuretic factor (ANF) during orthotopic liver transplantation in humans.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Female; Hemodynamics; Hum | 1994 |
Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.
Topics: Aldosterone; Ascites; Female; Hemodynamics; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Age | 2001 |
[Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Topics: Aldosterone; Ascites; Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperkalemi | 2001 |
Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Volume; Female; Homeostasis; Humans; Kidney; Liver Cir | 2001 |
[Effect of passive leg lifting on sodium excretion in patients with liver cirrhosis].
Topics: Adolescent; Adult; Aged; Aldosterone; Diuresis; Humans; Leg; Liver Cirrhosis; Middle Aged; Posture; | 2001 |
Dopaminergic control of renal tubular function in patients with compensated cirrhosis.
Topics: Adult; Aged; Aldosterone; Case-Control Studies; Dopamine; Dopamine Antagonists; Female; Humans; Imme | 2002 |
Effect of beta adrenergic blocking drugs on the renin-aldosterone system, sodium excretion, and renal hemodynamics in cirrhosis with ascites.
Topics: Adrenergic beta-Antagonists; Aldosterone; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Natriuresis | 1977 |
Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
Topics: Aldosterone; Ascites; Humans; Kidney; Liver Cirrhosis; Regional Blood Flow; Renin; Sodium | 1979 |
[Renin-angiotensin system in hepatic cirrhosis].
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Dogs; Humans; Juxtaglomerular Apparatus; Liver | 1979 |
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Body Weight; Budd-Chiari Syndrome; Cardiac Output; Diuresis; Drai | 1979 |
Blood pressure response to [1-sarcosine, 8-isoleucine] angiotensin II in patients with liver cirrhosis and ascites.
Topics: Aldosterone; Angiotensin II; Ascites; Blood Pressure; Humans; Liver Cirrhosis; Renin | 1979 |
[Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy].
Topics: Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Diuretics; Glucuronates; Humans; Hyperaldoster | 1979 |
[Role of secondary hyperaldosteronism in the pathomecanism of hydropic decompensation in the cirrhotic patient (author's transl)].
Topics: Adult; Aged; Aldosterone; Creatinine; Diuresis; Humans; Hyperaldosteronism; Liver Cirrhosis; Middle | 1979 |
Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.
Topics: Aldosterone; Ascites; Humans; Kidney; Liver Cirrhosis; Nephrons; Sodium | 1979 |
[Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Ascites; Electrolytes; Female; Humans; Hypera | 1979 |
The effect of propranolol on renal sodium handling in patients with cirrhosis.
Topics: Adult; Aged; Aldosterone; Diuresis; Female; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrho | 1979 |
LaVeen continuous peritoneal-jugular shunt. Improvement of renal function in ascitic patients.
Topics: Abdomen; Aldosterone; Blood Urea Nitrogen; Body Weight; Creatinine; Humans; Jugular Veins; Kidney; L | 1977 |
Peritoneovenous (LeVeen) shunt. Control of renin-aldosterone system in cirrhotic ascites.
Topics: Adult; Aldosterone; Ascites; Humans; Jugular Veins; Liver Cirrhosis; Male; Peritoneal Cavity; Renin; | 1978 |
Sodium metabolism.
Topics: Aldosterone; Edema; Extracellular Space; Female; Glomerular Filtration Rate; Heart Failure; Humans; | 1977 |
The role of renin and aldosterone in the salt retention of edema.
Topics: Aldosterone; Blood Pressure; Edema; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Cortex | 1977 |
Studies on the activity of the renin-angiotensin-aldosterone system (RAAS) in patients with cirrhosis of the liver.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensinogen; Ascites; Diuretics; Humans; Liver Cirrhos | 1978 |
[Renal perfusion and the renin-angiotensin system in hepatic cirrhosis].
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Humans; Kidney; Kidney Function Tests; Liver Cirrh | 1978 |
Role of renin-angiotensin system in the controls of blood pressure and aldosterone in patients with cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Ascites; Blood Pressure; Depression, Chemical; Female; Hum | 1978 |
The pathophysiology of sodium balance.
Topics: Aldosterone; Glomerular Filtration Rate; Heart Failure; Humans; Hypernatremia; Hyponatremia; Kidney; | 1978 |
Studies of volume homeostasis in man utilizing the model of head-out water immersion.
Topics: Aldosterone; Angiotensin II; Extracellular Space; Homeostasis; Humans; Immersion; Liver Cirrhosis; M | 1978 |
Characterization of the renin-aldosterone system in decompensated cirrhosis.
Topics: Adult; Aldosterone; Humans; Immersion; Kidney Function Tests; Liver Cirrhosis; Middle Aged; Osmolar | 1977 |
[Aldosterone and renin in liver cirrhosis with ascites].
Topics: Aldosterone; Ascites; Furosemide; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Renin; Spiron | 1977 |
Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Humans; Liver Cirrhosis; Renin; Sarala | 1976 |
[Kideny and hepato-biliary diseases].
Topics: Abdomen; Acidosis; Acute Kidney Injury; Aldosterone; Angiotensin II; Biliary Tract Diseases; Glomeru | 1976 |
[The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Diuresis; Female; Heart Rate; | 1976 |
The role of renin in the control of blood pressure in normotensive man.
Topics: Aldosterone; Blood Pressure; Diet; Humans; Liver Cirrhosis; Posture; Pulse; Renin; Saralasin; Sodium | 1976 |
Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Topics: Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Cushing Synd | 1976 |
[Hyperaldosteronism in acute viral hepatitis, liver cirrhosis and fulminating liver failure].
Topics: Aldosterone; Angiotensin II; Angiotensinogen; Corticosterone; Hepatic Encephalopathy; Hepatitis; Hum | 1976 |
[Hepatic aldosterone extraction and perfusion in liver cirrhosis].
Topics: Adult; Aldosterone; Esophageal and Gastric Varices; Humans; Liver; Liver Cirrhosis; Middle Aged | 1976 |
Studies of renin and aldosterone in cirrhotic patients with ascites.
Topics: Aldosterone; Ascites; Humans; Liver Cirrhosis; Renin; Sodium | 1975 |
[Renin and aldosterone].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Juxtaglomerular Apparatus; Li | 1975 |
Determinants of deranged sodium and water homeostasis in decompensated cirrhosis.
Topics: Adult; Aldosterone; Body Weight; Creatinine; Desoxycorticosterone; Diet; Homeostasis; Humans; Immers | 1976 |
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic G | 1992 |
Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Atrial Natriuretic Factor; Blood Pressure; Epinephrine; Female; G | 1992 |
Plasma endothelin levels in cirrhotic subjects.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Endotheli | 1992 |
Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Bed Rest; Blood Pressure; Female; Glomerular Fi | 1992 |
Plasma atrial natriuretic peptide and renin-aldosterone in patients with cirrhosis and ascites: basal levels, changes during daily activity and nocturnal diuresis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Bilirubin; Blood Pressure; Circadian Rhythm; Creati | 1992 |
Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
Topics: Aldosterone; Analysis of Variance; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Biomark | 1992 |
Refractory ascites: modulation of atrial natriuretic factor unresponsiveness by mannitol.
Topics: Aged; Aldosterone; Ascites; Aspartate Aminotransferases; Atrial Natriuretic Factor; Bilirubin; Human | 1992 |
Plasma levels of brain natriuretic peptide in patients with cirrhosis.
Topics: Alanine Transaminase; Aldosterone; Alkaline Phosphatase; Ascites; Aspartate Aminotransferases; Bilir | 1992 |
Effect of diltiazem on renal function in patients with liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Diltiazem; Drug Evaluation; Female; Humans; Kid | 1991 |
Role of atrial natriuretic factor in sodium and water retention in patients with schistosomal hepatic fibrosis.
Topics: Adolescent; Adult; Aldosterone; Atrial Natriuretic Factor; Body Water; Female; Humans; Liver Cirrhos | 1991 |
Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during the development of hepatic ascites.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Hemodynamics; Humans; Kidney Tubules | 1991 |
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Ascites; Diuretics; Drug Resistance; Electrolytes; Fema | 1991 |
Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
Topics: Adult; Aged; Aldosterone; Ascites; Blood Pressure; Blood Volume; Diet, Sodium-Restricted; Female; Ho | 1991 |
Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
Topics: Aged; Aldosterone; Ascites; Blood Pressure; Body Water; Creatine; Electrolytes; Glomerular Filtratio | 1991 |
Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Deoxyepinephrine; Diuretics; Dopamine; Dopamine Agents; Glomerular Filtrat | 1990 |
[Relation between chronic hepatitis and cirrhosis in the type of differentiation of symptoms and signs and endocrine hormone].
Topics: Adult; Aged; Aldosterone; Female; Hepatitis B; Hepatitis, Chronic; Humans; Liver Cirrhosis; Male; Me | 1991 |
[The clinical importance of determining aldosterone in the ascitic fluid].
Topics: Aldosterone; Ascites; Ascitic Fluid; Humans; Liver Cirrhosis; Radioimmunoassay | 1990 |
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance.
Topics: Aldosterone; Ascites; Female; Glomerular Filtration Rate; Humans; Kidney Tubules; Lithium; Liver Cir | 1990 |
Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, A | 1990 |
[The effect of dopamine on hemodynamic and hormonal parameters in liver cirrhosis].
Topics: Aldosterone; Atrial Natriuretic Factor; Catecholamines; Dopamine; Hemodynamics; Hormones; Humans; Li | 1990 |
[Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
Topics: Aldosterone; Ascites; Atrial Natriuretic Factor; Extracellular Space; Humans; Hypertension; Kidney; | 1990 |
Intrapatient comparison of acute hemodynamic, hormonal, and natriuretic responses to captopril versus enalapril in liver cirrhosis.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Enalapril; Female; Heart Rate; Hemodynamics; Ho | 1990 |
Circadian rhythm of atrial natriuretic peptide, plasmatic renin activity, and plasma aldosterone in compensated cirrhosis of the liver.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Circadian Rhythm; Female; Humans; Liver Cirrhosis; Ma | 1989 |
Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Body Fluids; Humans; Immersion; Kidney; Liver C | 1989 |
[Reaction of the cardiovascular and humoral system to acute hypervolemia in patients with liver cirrhosis].
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Volume; Female; Hemodynamics; Humans; | 1989 |
[Recent advances in the clinical study of the renin system. Reference values and conditions of validity].
Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Angiotensinogen; Enzyme Precursors; Estrogens; Fe | 1989 |
[Circadian rhythm of atrial natriuretic peptide, plasma renin and aldosterone activity in healthy subjects and in patients with compensated liver cirrhosis].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Circadian Rhythm; Female; Humans; Liver Cirrhosis; Ma | 1989 |
Atrial natriuretic peptide-renin-aldosterone system in cirrhosis of the liver: circadian study.
Topics: Adult; Aldosterone; Ascites; Atrial Natriuretic Factor; Circadian Rhythm; Female; Humans; Liver Cirr | 1989 |
Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Blood Pressure; Catecholamines; Female | 1989 |
Atrial natriuretic factor in liver cirrhosis--the influence of volume expansion.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Volume; Body Weight; Humans; Liver Cirrhosis; Renin | 1989 |
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Atrial Natriuretic Factor; Cyclic GMP; Female; Glomerular Filtrat | 1989 |
[Hormonal changes in chronic diffuse diseases of the liver].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Chronic Disease; Female; Hepatitis, Chronic; Humans | 1989 |
Clinical, biochemical, and hormonal changes after a single, large-volume paracentesis in cirrhosis with ascites.
Topics: Aged; Aldosterone; Arginine Vasopressin; Ascites; Female; Humans; Kidney Function Tests; Liver Cirrh | 1989 |
Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.
Topics: Aldosterone; Female; Hemodynamics; Hepatorenal Syndrome; Humans; Kidney Diseases; Kidney Function Te | 1989 |
New classification with prognostic value in cirrhotic patients.
Topics: Adult; Aldosterone; Blood Volume; Diuresis; Female; Humans; Kidney; Liver Cirrhosis; Liver Cirrhosis | 1989 |
[Changes in antidiuretic hormone (ADH) in liver cirrhosis with resistant ascites].
Topics: Aged; Aldosterone; Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Potassium; Renin; So | 1989 |
[Clinical assessment of electrolyte metabolism and the renin-aldosterone system in patients with liver cirrhosis and ascites].
Topics: Adult; Aldosterone; Ascites; Electrolytes; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis; Live | 1989 |
Renal hemodynamics and the renin-angiotensin system in cirrhosis.
Topics: Adult; Aged; Aldosterone; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Renal Circulation; Ren | 1989 |
Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Cyclic GMP; Female; Humans; Immersion; Kidney; | 1988 |
Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors.
Topics: Adult; Aged; Aldosterone; Circadian Rhythm; Diuresis; Glomerular Filtration Rate; Humans; Hydrocorti | 1989 |
Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Diet, Sodium-Restricted; Edema; Heart Failure; Humans | 1985 |
Plasma atrial natriuretic factor in cirrhotic patients with ascites. Effect of peritoneovenous shunt implantation.
Topics: Aged; Aldosterone; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Female; Humans; Liver C | 1988 |
Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Epinephrine; Female; Humans; Liver Cirrhosis; L | 1988 |
Radioimmunoassay of atrial natriuretic peptide in human plasma: application to studies of volume and blood pressure homeostasis.
Topics: Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Electrolytes; Extracellular Space; Heart Fai | 1988 |
[Atrial natriuretic factor in liver cirrhosis. The effect of volume loading].
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Volume; Humans; Liver Cirrhosis; Middle Aged; R | 1988 |
Hyperresponsiveness to water immersion in sodium retaining cirrhotics: the role of atrial natriuretic factor.
Topics: Aldosterone; Atrial Natriuretic Factor; Creatinine; Humans; Immersion; Liver Cirrhosis; Natriuresis; | 1988 |
Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Topics: Aldosterone; Atrial Natriuretic Factor; Carcinoma, Hepatocellular; Chronic Disease; Female; Hepatiti | 1987 |
[The renin-angiotensin-aldosterone system in chronic diseases of the liver].
Topics: Adult; Aldosterone; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Middle Aged; Renin; Renin-A | 1988 |
[Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
Topics: Aldosterone; Anesthesia, Epidural; Canrenoic Acid; Humans; Liver Cirrhosis; Potassium; Pregnadienes; | 1988 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; | 1988 |
Role of intestinal bacteria in the metabolism of aldosterone in man.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aldosterone; Bacteria, Anaerobic; Female; Humans; Intestinal M | 1988 |
Effect of captopril on renin and blood pressure in cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Blood Pressure; Captopril; Epinephrine; Female; Humans; | 1987 |
Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis.
Topics: Adult; Aged; Aldosterone; Glomerular Filtration Rate; Humans; Liver Cirrhosis; Male; Metoclopramide; | 1988 |
Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
Topics: Aldosterone; Ascites; Bilirubin; Cholinesterases; Chronic Disease; Depression, Chemical; Humans; Ind | 1986 |
The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
Topics: Aldosterone; Ascites; Creatinine; Furosemide; Humans; Kidney; Liver Cirrhosis; Natriuresis; p-Aminoh | 1986 |
[Surgical treatment of the ascitic patient using LeVeen peritoneojugular shunt. Personal case reports].
Topics: Aldosterone; Ascites; Female; Humans; Jugular Veins; Liver Cirrhosis; Male; Middle Aged; Peritoneove | 1986 |
Renal prostaglandins in cirrhosis of the liver.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Kidney Injury; Adult; Aged; Aldosterone; Creatinine; Dinoprost; | 1986 |
[Prolactin in plasma and ascitic fluid in hepatic cirrhosis. Its relation to plasma and urinary electrolytes].
Topics: Adult; Aged; Aldosterone; Ascitic Fluid; Electrolytes; Humans; Liver Cirrhosis; Male; Middle Aged; P | 1986 |
Chronobiological study of factors affecting plasma aldosterone concentration in cirrhosis.
Topics: Adult; Aged; Aldosterone; Circadian Rhythm; Humans; Hydrocortisone; Liver Cirrhosis; Liver Cirrhosis | 1986 |
[Systemic hyperdynamic circulation and serum hormone concentrations in portal hypertension].
Topics: Adult; Aldosterone; Female; Glucagon; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; M | 1986 |
Hyporeninemic hypoaldosteronism in a patient with cirrhosis and ascites.
Topics: Aldosterone; Ascites; Diabetic Nephropathies; Female; Humans; Liver Cirrhosis; Middle Aged; Renin | 1986 |
Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses.
Topics: Adult; Aged; Aldosterone; Arginine; Ascites; Blood Pressure; Female; Humans; Liver Cirrhosis; Male; | 1987 |
Relationship between aldosterone and sodium, potassium, and uric acid clearance in cirrhosis with and without ascites.
Topics: Adult; Aldosterone; Ascitic Fluid; Female; Humans; Kinetics; Liver Cirrhosis; Male; Metabolic Cleara | 1986 |
Renal function impairment induced by change in posture in patients with cirrhosis and ascites.
Topics: Adult; Aged; Aldosterone; Humans; Kidney Diseases; Kidney Function Tests; Liver; Liver Cirrhosis; Ma | 1985 |
The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Topics: Aldosterone; Angiotensin II; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Renin; Renin-Angiot | 1985 |
Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.
Topics: Aldosterone; Diuretics; Dose-Response Relationship, Drug; Humans; Liver Cirrhosis; Mineralocorticoid | 1985 |
[Edemas--review of pathogenesis].
Topics: Aldosterone; Blood Proteins; Edema; Edema, Cardiac; Extracellular Space; Glomerular Filtration Rate; | 1985 |
[Role of aldosterone in the development of edema].
Topics: Aldosterone; Edema; Female; Heart Failure; Humans; Liver Cirrhosis; Middle Aged; Nephrotic Syndrome | 1985 |
Angiotensin-induced natriuresis in cirrhosis in the absence of endogenous aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Ascites; Female; Humans; In Vitro Techniques; Liver Cirrhosis; Middle A | 1966 |
The effects of aldosterone and angiotensin on renal function.
Topics: Adult; Aldosterone; Angiotensin II; Ascites; Edema; Female; Humans; In Vitro Techniques; Kidney; Kid | 1966 |
[Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
Topics: Aldosterone; Angiotensin II; Ascites; Diabetes Insipidus; Heart Failure; Humans; Hypertension; Jaund | 1966 |
Role of aldosterone in edema formation.
Topics: Aldosterone; Angiotensin II; Edema; Heart Failure; Humans; Hyperaldosteronism; Kidney; Liver; Liver | 1966 |
Angiotensin-aldosterone interrelationship in liver cirrhosis.
Topics: Aldosterone; Angiotensin II; Humans; Liver Cirrhosis | 1967 |
[The physiological relationship between the renin-angiotensin system and aldosterone].
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Heart Failure; Humans; Hyperald | 1965 |
Acute renal vein hypertension: oliguria, hormone infusion, and volume expansion.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Anuria; Dogs; Glomerular Filtration Rate; Hyper | 1969 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Angiotensin II; Heart Failure; Hyperaldosteronism; Hyperkalemia; Hypertension, Malignan | 1969 |
[Angiotensin-aldosterone interrelations in hepatic cirrhosis].
Topics: Aldosterone; Angiotensin II; Ascites; Edema; Humans; Liver Cirrhosis; Natriuresis; Potassium | 1970 |
[Hormonal disorders in liver insufficiency].
Topics: Adrenocorticotropic Hormone; Aldosterone; Endocrine System Diseases; Humans; Liver Cirrhosis; Liver | 1969 |
[Autoperfusion of ascitic fluid in cirrhosis. Effects on elimination of water, sodium and potassium].
Topics: Aldosterone; Ascitic Fluid; Diuresis; Glomerular Filtration Rate; Humans; Injections, Intravenous; L | 1971 |
[Clinical studies on the relation between aldosterone and various hypertensive and renal diseases. 2. Studies on the effect of synthetic angiotensin II on aldosterone secretion rate].
Topics: Addison Disease; Aldosterone; Angiotensin II; Blood Pressure; Humans; Hypertension; Injections, Intr | 1971 |
Effect of prostaglandin A 1 on renal and adrenal function in man.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood Pressure; Calcium; Creatinine; Cyclic AMP; Edema; Glomer | 1972 |
[Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Cardanolides; Diet, Sodium-Restricted; Diureti | 1973 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
[Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Hemodynamics; Humans; Hyperaldosteroni | 1974 |
Idiopathic edema.
Topics: Adult; Age Factors; Aldosterone; Edema; Female; Heart Failure; Humans; Hydrochlorothiazide; Hydrosta | 1974 |
Letter: Initiation of the potassium-depleted state of the cirrhotic-a carbohydrate, insulin and aldosterone conspiracy?
Topics: Aldosterone; Dietary Carbohydrates; Humans; Insulin; Liver Cirrhosis; Potassium | 1974 |
Abnormal iron and water metabolism in acute intermittent porphyria with new morphologic findings.
Topics: Aldosterone; Arrhythmias, Cardiac; Autopsy; Body Water; Epinephrine; Hemosiderosis; Humans; Hypotens | 1972 |
Studies of the mechanism of sodium retention in idiopathic edema.
Topics: Adolescent; Adult; Aldosterone; Blood Proteins; Body Weight; Edema; Estradiol; Female; Glomerular Fi | 1973 |
Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
Topics: Acetazolamide; Adult; Aldosterone; Ascites; Female; Furosemide; Heart Failure; Heart Valve Diseases; | 1968 |
Physiologic aspects of edema.
Topics: Aldosterone; Animals; Blood Vessels; Body Water; Capillary Permeability; Dogs; Edema; Heart Failure; | 1972 |
[Studies on transcortin and aldosterone-binding proteins in human plasma. II. Studies on the plasma protein binding of various radioactive steroid hormones in patients with various disorders, pregnant women and estrogen-treated patients].
Topics: Addison Disease; Adolescent; Adult; Aged; Aldosterone; Blood Proteins; Carbon Isotopes; Cushing Synd | 1971 |
The use of glucocorticoids for diuresis in patients with fluid retention not resulting from renal disease.
Topics: Aldosterone; Chlorothiazide; Diuresis; Edema; Glomerular Filtration Rate; Glucocorticoids; Heart Dis | 1966 |
[Aldosterone in liver cirrhosis].
Topics: Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Middle Aged | 1969 |
Desoxycorticosterone secretion rate studies in edematous patients.
Topics: Adult; Aged; Aldosterone; Desoxycorticosterone; Edema; Female; Heart Failure; Humans; Liver Cirrhosi | 1970 |
[Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
Topics: Adult; Aged; Aldosterone; Ascites; Diuretics; Female; Furosemide; Humans; Hydrochlorothiazide; Liver | 1970 |
Spironolactone diuresis in patients with cirrhosis and ascites.
Topics: Alcoholism; Aldosterone; Ascites; Humans; Liver Cirrhosis; Potassium; Sodium; Spironolactone | 1970 |
[Clinical evaluation of a new method for the determination of urinary aldosterone].
Topics: Aldosterone; Chromatography, Thin Layer; Edema; Female; Heart Diseases; Humans; Hyperaldosteronism; | 1971 |
[The content of aldosterone in the urine in patients with liver cirrhosis].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Liver Cirrhosis; Male; Middle Aged | 1967 |
[Clinical studies on the effects of aldosterone and anti-aldosterone compounds on water and electrolyte metabolism. I. Clinical studies on the effects of aldosterone and anti-aldosterone compounds which act on renal tubule of water and electrolyte metabol
Topics: Addison Disease; Adolescent; Adult; Aldosterone; Female; Humans; Kidney Diseases; Kidney Tubules; Li | 1967 |
Amiloride. A potassium-sparing natriuretic agent.
Topics: Acetazolamide; Aldosterone; Ammonia; Ascites; Bicarbonates; Blood Pressure; Chlorides; Chlorothiazid | 1968 |
[On the isolation of 18-aldosterone glucuronide and tetrahydroaldosterone glucuronide from human urine].
Topics: Aldosterone; Aluminum; Chromatography; Chromatography, Paper; Ethanol; Glucuronates; Humans; Liver C | 1968 |
[Physiopathology and treatment of hyponatremia (II)].
Topics: Adrenal Insufficiency; Aldosterone; Anesthesia; Diuretics; Heart Diseases; Humans; Hyperpituitarism; | 1968 |
[Secretion, plasma concentration, distribution, metabolism and excretion of aldosterone in healthy and sick subjects].
Topics: Aldosterone; Edema; Glomerulonephritis; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Liv | 1968 |
Secretion and turnover of aldosterone in various pathological states.
Topics: Adolescent; Adult; Aldosterone; Chronic Disease; Dehydration; Edema; Glomerulonephritis; Heart Failu | 1969 |
The effects of aldosterone and glucocorticoid on free water reabsorption.
Topics: Absorption; Aldosterone; Diuresis; Humans; Infusions, Parenteral; Kidney; Liver Cirrhosis; Mannitol; | 1965 |
[On ati-aldosterone therapy in liver cirrhosis].
Topics: Aldosterone; Humans; Liver Cirrhosis | 1965 |
Urinary sodium and aldosterone excretion following portocaval shunts for cirrhosis of liver and portal hypertension: effect of end-to-side and side-to-side anastomoses in 16 cases.
Topics: Aldosterone; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Function Tests; Natriuresis; Porta | 1966 |